Aghilipour H, Fiedler S, Funk MB (2022): Zuständigkeiten des Paul-Ehrlich-Instituts auf der Basis der neuen EU-Verordnung für In-vitro-Diagnostika.
Bulletin zur Arzneimittelsicherheit 13: 9-15.
Text

Albrecht M, Halle O, Gaedcke S, Pallenberg ST, Camargo Neumann J, Witt M, Roediger J, Schumacher M, Jirmo AC, Warnecke G, Jonigk D, Braubach P, DeLuca D, Hansen G, Dittrich AM (2022): Interleukin-17A and interleukin-22 production by conventional and non-conventional lymphocytes in three different end-stage lung diseases.
Clin Transl Immunology 11: e1398.
Text

Albrecht M, Schaub B, Gilles S, Köhl J, Altrichter S, Voehringer D, Spillner E, Ehlers M, Jönsson F, Loser K, Mayer JU, Rösner LM, Möbs C, Heine G, Pfützner W (2022): Current research and unmet needs in allergy and immunology in Germany: report presented by the DGfI and DGAKI task force Allergy & Immunology.
Eur J Immunol 52: 851-855.
Text

Alirezaeizanjani Z, Trösemeier JH, Kamp C, Rudorf S (2022): Tailoring Codon Usage to the Underlying Biology for Protein Expression Optimization.
Methods Mol Biol 2406: 85-92.
Online-Abstract

Anliker B, Childs L, Rau J, Renner M, Schüle S, Schuessler-Lenz M, Sebe A (2022): Regulatory Considerations for Clinical Trial Applications with CRISPR-Based Medicinal Products.
CRISPR J 5: 364-376.
Online-Abstract

Arrazuria R, Kerscher B, Huber KE, Hoover JL, Lundberg CV, Hansen JU, Sordello S, Renard S, Aranzana-Climent V, Hughes D, Gribbon P, Friberg LE, Bekeredjian-Ding I (2022): Expert workshop summary: Advancing toward a standardized murine model to evaluate treatments for antimicrobial resistance lung infections.
Front Microbiol 13: 988725.
Text

Arrazuria R, Kerscher B, Huber KE, Hoover JL, Lundberg CV, Hansen JU, Sordello S, Renard S, Aranzana-Climent V, Hughes D, Gribbon P, Friberg LE, Bekeredjian-Ding I (2022): Variability of murine bacterial pneumonia models used to evaluate antimicrobial agents.
Front Microbiol 13: 988728.
Text

Arroyo M, Hastert FD, Zhadan A, Schelter F, Zimbelmann S, Rausch C, Ludwig AK, Carell T, Cardoso MC (2022): Isoform-specific and ubiquitination dependent recruitment of Tet1 to replicating heterochromatin modulates methylcytosine oxidation.
Nat Commun 13: 5173.
Text

Artunc F, Bohnert BN, Schneider JC, Staudner T, Sure F, Ilyaskin AV, Wörn M, Essigke D, Janessa A, Nielsen NV, Birkenfeld AL, Etscheid M, Haerteis S, Korbmacher C, Kanse SM (2022): Proteolytic activation of the epithelial sodium channel (ENaC) by factor VII activating protease (FSAP) and its relevance for sodium retention in nephrotic mice.
Pflugers Arch 474: 217-229.
Online-Abstract

Atemnkeng J, Heinrich J, Samukange WT, Kafere C, Mbunkah HA, Schoner C, Reinhardt J (2022): Report on the GHPP-BloodTrain online workshop on "Authorisation and Licensing of Blood Establishments - Review of quality documentation of blood and blood components", 5th-8th of July 2021.
Biologicals 80: 1-5.
Text

Auste A, Mühlebach MD (2022): Concentrating all helper protein functions on a single entity allows rescue of recombinant measles virus by transfection of just two plasmids.
J Gen Virol 103: 001815.
Text

Baylis SA, Adlhoch C, Childs L, and the HEV Sequencing Study Group (2022): An Evaluation of Hepatitis E Virus Molecular Typing Methods.
Clin Chem 68: 181-191.
Text

Baylis SA, Nübling CM (2022): Nucleic Acid Testing of Viral Pathogens: Traceability of the International Unit.
Clin Chem 68: 257-258.
Text

Baylis SA, O'Flaherty N, Burke L, Hogema B, Corman VM (2022): Identification of rabbit hepatitis E virus (HEV) and novel HEV clade in Irish blood donors.
J Hepatol 77: 870-872.
Text

Behr-Gross ME, Regourd E, Holtkamp W (2022): Collaborative study for the establishment of Ph. Eur. Human immunoglobulin for electrophoresis BRP batch 4.
Pharmeur Bio Sci Notes 2022: 37-54.
Online-Abstract

Bender D, Glitscher M, Hildt E (2022): Die Virushepatitiden A bis E: Prävalenz, Erregermerkmale und Pathogenese.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65: 139-148.
Text

Bender D, Hildt E (2022): Back to the Roots: Noncanonical Retrograde Trafficking of the HBV Nucleocapsids.
Cell Mol Gastroenterol Hepatol 15: 797-798.
Text

Berg P, Schönefeld S, Ruppert-Seipp G, Funk MB (2022): Regulatory Measures to Improve the Safety of CAR-T-Cell Treatment.
Transfus Med Hemother 50: 218-225.
Text

Berge-Seidl S, Nielsen NV, Rodriguez Alfonso AA, Etscheid M, Kandanur SPS, Haug BE, Stensland M, Thiede B, Karacan M, Preising N, Wiese S, Ständker L, Declerck PJ, Løset GÅ, Kanse SM (2022): Identification of a Phage Display-Derived Peptide Interacting with the N-Terminal Region of Factor VII Activating Protease (FSAP) Enables Characterization of Zymogen Activation.
ACS Chem Biol 17: 2631-2642.
Text

Bergner S, Grüger T, Huber M, Lütkehermölle W, Paeschke N, Palissa H, Stephan K, Cibura S, Keller-Stanislawski B (2022): Instrumente behördlicher Kommunikation zu Anwendungsrisiken von Arzneimitteln.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65: 567-576.
Text

Bernard MC, Waldock J, Commandeur S, Strauß L, Trombetta CM, Marchi S, Zhou F, van de WItte S, van Amsterdam P, Ho S, Hoschler K, Lugovtsev V, Weir JP, Montomoli E, Cox RJ, Engelhardt OG, Friel D, Wagner R, Ollinger T, Germain S, Sediri-Schön H (2022): Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study.
Front Immunol 13: 909297.
Text

Bexte T, Botezatu L, Miskey C, Reindl LM, Campe J, Mertlitz S, Gebel V, Schubert R, Cremer A, Rettinger E, Prommersberger S, Penack O, Wels WS, Hudecek M, Ivics Z, Ullrich E (2022): High antileukemic efficiency of CD19-CAR NK cells engineered with Sleeping Beauty transposon vectors.
Klin Padiatr 234: 190-191.
Online-Abstract

Blanco-Pérez F, Gonzalez-Menendez I, Stassen M, Kato Y, Laiño J, Kirberg J, Krause M, Martella M, Shibata N, Quintanilla-Martinez L, Feyerabend TB, Rodewald HR, Galli SJ, Vieths S, Scheurer S, Toda M (2022): Mast cells partly contribute to allergic enteritis development: findings in two different mast cell-deficient mice.
Allergy 77: 1051-1054.
Online-Abstract

Bold CS, Baltissen D, Ludewig S, Back MK, Just J, Kilian L, Erdinger S, Banicevic M, Rehra L, Almouhanna F, Nigri M, Wolfer DP, Spilger R, Rohr K, Kann O, Buchholz CJ, von Engelhardt J, Korte M, Müller UC (2022): APPsα Rescues Tau-Induced Synaptic Pathology.
J Neurosci 42: 5782-5802.
Online-Abstract

Bonertz A, Tripathi A, Zimmer J, Reeb C, Kaul S, Bridgewater J, Rabin RL, SI JE, Vieths S (2022): A regulator’s view on AIT clinical trials in the United States and Europe: Why successful studies fail to support licensure.
J Allergy Clin Immunol 149: 812-818.
Online-Abstract

Breitenbach T, Englert N, Osmanoglu Ö, Rukoyatkina N, Wangorsch G, Heinze K, Friebe A, Butt E, Feil R, Dittrich M, Gambaryan S, Dandekar T (2022): A modular systems biological modelling framework studies cyclic nucleotide signaling in platelets.
J Theor Biol 550: 111222.
Text

Chapman MD, Custovic A, Mills CEN, Holzhauser T: Molecular exposure: Systematic approaches, clinical significance, and harmonisation.
In: Hoffmann-Sommergruber K, Hilger C, Santos A, de las Vecillas L, Dramburg S / EAACI (Hrsg.), Molecular Allergology User’s Guide 2.0: John Wiley & Sons Ltd., 2022. S. 157-170, ISBN 978-3-9524815-4-7

Costa J, Bavaro SL, Benedé S, Diaz-Perales A, Bueno-Diaz C, Gelencser E, Klueber J, Larré C, Lozano-Ojalvo D, Lupi R, Mafra I, Mazzuchelli G, Molina E, Monaci L, Martin-Petraza L, Piras C, Rodrigues PM, Roncada P, Schrama D, Cirkovic-Velickovic T, Verhoeckx K, Villa C, Kuehn A, Hoffmann-Sommergruber K, Holzhauser T (2022): Are Physicochemical Properties Shaping the Allergenic Potency of Plant Allergens?.
Clin Rev Allergy Immunol 62: 37-63.
Online-Abstract

Demircan MB, Mgbecheta PC, Kresinsky A, Schnoeder TM, Schröder K, Heidel FH, Böhmer FD (2022): Combined Activity of the Redox-Modulating Compound Setanaxib (GKT137831) with Cytotoxic Agents in the Killing of Acute Myeloid Leukemia Cells.
Antioxidants (Basel) 11: 513.
Text

Demircan MB, Schnoeder TM, Mgbecheta PC, Schröder K, Böhmer FD, Heidel FH (2022): Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML).
J Cancer Res Clin Oncol 148: 1983–1990.
Text

Denk D, Petrocelli V, Conche C, Drachsler M, Ziegler PK, Braun A, Kress A, Nicolas AM, Mohs K, Becker C, Neurath MF, Farin HF, Buchholz CJ, Andreux PA, Rinsch C, Greten FR (2022): Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy.
Immunity 55: 2059-2073.
Text

Dickel H, Bauer A, Brehler R, Mahler V, Merk HF, Neustädter I, Strömer K, Werfel T, Worm M, Geier J (2022): S1-Leitlinie Kontaktekzem.
J Dtsch Dermatol Ges 20: 711-734.
Text

Ding L, Li J, Li X, Qu B (2022): Evolutionary and Mutational Characterization of the First H5N8 Subtype Influenza A Virus in Humans.
Pathogens 11: 666.
Text

Donnadieu E, Luu M, Alb M, Anliker B, Arcangeli S, Bonini C, De Angelis B, Choudhary R, Espie D, Galy A, Holland C, Ivics Z, Kantari-Mimoun C, Kersten MJ, Köhl U, Kuhn C, Laugel B, Locatelli F, Marchiq I, Markman J, Moresco MA, Morris E, Negre H, Quintarelli C, Rade M, Reiche K, Renner M, Ruggerio E, Sanges C, Stauss H, Themeli M, Van den Brulle J, Hudecek M, Casucci M (2022): Time to evolve: predicting engineered T cell-associated toxicity with next-generation models.
J Immunother Cancer 10: e003486.
Text

Ebenig A, Lange MV, Mühlebach MD (2022): Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines.
NPJ Vaccines 7: 119.
Online-Abstract

Ebenig A, Muraleedharan S, Kazmierski J, Todt D, Auste A, Anzaghe M, Gömer A, Postmus D, Gogesch P, Niles M, Plesker R, Miskey C, Gellhorn Serra M, Breithaupt A, Hörner C, Kruip C, Ehmann R, Ivics Z, Waibler Z, Pfaender S, Wyler E, Landthaler M, Kupke A, Nouailles G, Goffinet C, Brown RJP, Mühlebach MD (2022): Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after TH2-biased immunization.
Cell Rep 40: 111214.
Online-Abstract

Eisenbrand G, Baum M, Cartus AT, Diel P, Engel KH, Engeli B, Epe B, Grune T, Guth S, Haller D, Heinz V, Hellwig M, Hengstler JG, Henle T, Humpf HU, Jäger H, Joost HG, Kulling S, Lachenmeier DW, Lampen A, Leist M, Mally A, Marko D, Nöthlings U, Röhrdanz E, Roth A, Spranger J, Stadler R, Vieths S, Wätjen W, Steinberg P (2022): Salivary nitrate/nitrite and acetaldehyde in humans: potential combination effects in the upper gastrointestinal tract and possible consequences for the in vivo formation of N-nitroso compounds-a hypothesis.
Arch Toxicol 96: 1905-1914.
Text

Etscheid M, Hanschmann KM, Sandset PM, Kanse SM (2022): Development of a Factor VII Activating Protease (FSAP) generation assay and its application in studying FSAP in venous thrombosis.
Thromb Res 220: 24-34.
Online-Abstract

Fekadu J, Modlich U, Bader P, Bakhtiar S (2022): Understanding the Role of LFA-1 in Leukocyte Adhesion Deficiency Type I (LAD I): Moving towards Inflammation?.
Int J Mol Sci 23: 3578.
Online-Abstract

Fischer N, Gulich B, Tönjes RR, Godehardt AW (2022): Limited environmental stability of infectious porcine endogenous retrovirus type C; Usage of reverse transcriptase in combination with viral RNA as markers for infectious virus.
Xenotransplantation 29: e12738.
Text

Gasparics Á, Sebe A (2022): Forward Genetic Screens as Tools to Investigate Role and Mechanisms of EMT in Cancer.
Cancers (Basel) 14: 5928.
Text

Geier J, Ballmer-Weber B, Buhl T, Rieker-Schwienbacher J, Mahler V, Dickel H, Schubert S, IVDK (2022): Is benzyl alcohol a significant contact sensitizer?.
J Eur Acad Dermatol Venereol 36: 866-872.
Text

Glitscher M, Hildt E, Bender D (2022): Hepatitis B und C: Mechanismen der virusinduzierten Leberpathogenese und Tumorentstehung.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65: 228-237.
Text

Gömer A, Brown RJP, Pfaender S, Deterding K, Reuter G, Orton R, Seitz S, Bock CT, Cavalleri JMV, Pietschmann T, Wedemeyer H, Steinmann E, Todt D (2022): Intra-host analysis of hepaciviral glycoprotein evolution reveals signatures associated with viral persistence and clearance.
Virus Evol 8: veac007.
Text

Görgülü E, Gu W, Trebicka J, Mücke VT, Mücke MM, Friedrich-Rust M, Bojunga J, Zeuzem S, Finkelmeier F, Peiffer KH (2022): Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: another collateral damage of the COVID-19 pandemic?.
Gut 71: 1036-1038.
Text

Goretzki A, Lin YJ, Zimmermann J, Rainer H, Junker AC, Wolfheimer S, Vieths S, Scheurer S, Schülke S (2022): Role of Glycolysis and Fatty Acid Synthesis in the Activation and T Cell-Modulating Potential of Dendritic Cells Stimulated with a TLR5-Ligand Allergen Fusion Protein.
Int J Mol Sci 23: 12695.
Text

Goretzki A, Zimmermann J, Lin YJ, Schülke S (2022): Immune Metabolism-An Opportunity to Better Understand Allergic Pathology and Improve Treatment of Allergic Diseases?.
Front Allergy 3: 825931.
Text

Gramstad OR, Kandanur SPS, Etscheid M, Nielsen EW, Kanse SM (2022): Factor VII activating protease (FSAP) is not essential in the pathophysiology of angioedema in patients with C1 inhibitor deficiency.
Mol Immunol 142: 95-104.
Online-Abstract

Guedan S, Luu M, Ammar D, Barbao P, Bonini C, Bousso P, Buchholz CJ, Casucci M, De Angelis B, Donnadieu E, Espie D, Greco B, Groen R, Huppa JB, Kantari-Mimoun C, Laugel B, Mantock M, Markman JL, Morris E, Quintarelli C, Rade M, Reiche K, Rodriguez-Garcia A, Rodriguez-Madoz JR, Ruggiero E, Themeli M, Hudecek M, Marchiq I (2022): Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?.
J Immunother Cancer 10: e003487.
Text

Guimaraes Koch SS, Thorpe R, Kawasaki N, Lefranc MP, Malan S, Martin ACR, Mignot G, Plückthun A, Rizzi M, Shubat S, Weisser K, Balocco R (2022): International nonproprietary names for monoclonal antibodies: an evolving nomenclature system.
MAbs 14: 2075078.
Online-Abstract

Hastert FD, Hein S, von Rhein C, Benz NI, Husria Y, Oberle D, Maier TJ, Hildt E, Schnierle BS (2022): The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination.
Vaccines (Basel) 10: 794.
Text

Hastert FD, Henss L, von Rhein C, Gerbeth J, Wieters I, Borgans F, Khodamoradi Y, Zacharowski K, Rohde G, Vehreschild MJGT, Schnierle B (2022): Longitudinal Analysis of Coronavirus-Neutralizing Activity in COVID-19 Patients.
Viruses 14: 882.
Text

Hauptstein N, Dirauf M, Wittwer K, Cinar G, Siering O, Raschig M, Lühmann T, Scherf-Clavel O, Sawatsky B, Nischang I, Schubert US, Pfaller CK, Meinel L (2022): PEtOxylated Interferon-α2a Bioconjugates Addressing H1N1 Influenza A Virus Infection.
Biomacromolecules 23: 3593-3601.
Text

Hauptstein N, Pouyan P, Wittwer K, Cinar G, Scherf-Clavel O, Raschig M, Licha K, Lühmann T, Nischang I, Schubert US, Pfaller CK, Haag R, Meinel L (2022): Polymer selection impacts the pharmaceutical profile of site-specifically conjugated Interferon-α2a.
J Control Release 348: 881-892.
Text

Heim C, Moser LM, Merker M, Wels WS, Ivics Z, Bönig H, Ullrich E, Klusmann JH, Bader P, Rettinger E (2022): ErbB2-CAR mediated immunotherapy for the treatment of high-risk rhabdomyosarcoma.
Klin Padiatr 234: 190.
Online-Abstract

Hein S, Herrlein ML, Mhedhbi I, Bender D, Haberger V, Benz N, Eisert J, Stingl J, Dreher M, Oberle D, Schulze J, Mache C, Budt M, Hildt C, Wolff T, Hildt E (2022): Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera towards SARS-CoV-2 viruses.
Allergy 77: 2080–2089.
Online-Abstract

Hein S, Mhedhbi I, Zahn T, Sabino C, Benz NI, Husria Y, Renelt PM, Braun F, Oberle D, Maier TJ, Hildt C, Hildt E (2022): Quantitative and Qualitative Difference in Antibody Response against Omicron and Ancestral SARS‐CoV‐2 after Third and Fourth Vaccination.
Vaccines (Basel) 10: 796.
Text

Herrlein ML, Hein S, Zahn T, Mhedhbi I, Raupach J, Husria Y, Benz NI, Eisert J, Bender D, Haberger V, Hastert FD, Henss L, Schnierle BS, Stingl JC, Dreher M, Hildt E (2022): Comparative Investigation of Methods for Analysis of SARS-CoV-2-Spike-Specific Antisera.
Viruses 14: 410.
Text

Herrlein ML, Schmanke P, Elgner F, Sabino C, Akhras S, Bender D, Glitscher M, Tabari D, Scholl C, Stingl J, Hildt E (2022): Catch Me if You Can: the Crosstalk of Zika Virus and the Restriction Factor Tetherin.
J Virol 96: e0211721.
Online-Abstract

Hildt E (2022): Virale Hepatitis – ein versteckter Killer.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65: 137-138.
Text

Hildt E (2022): Übersicht über die in der EU zugelassenen COVID-19-Impfstoffe – von der Technologie über die klinische Prüfung zur Zulassung.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65: 1237–1243.
Text

Hildt E, Schaade L (2022): Impfungen als Instrument der Pandemiebewältigung.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65: 1235-1236.
Text

Ho N, Agarwal S, Milani M, Cantore A, Buchholz CJ, Thalheimer FB (2022): In vivo generation of CAR T cells in the presence of human myeloid cells.
Mol Ther Methods Clin Dev 26: 144-156.
Text

Huber S, Braun NJ, Schmacke LC, Quek JP, Murra R, Bender D, Hildt E, Luo D, Heine A, Steinmetzer T (2022): Structure-Based Optimization and Characterization of Macrocyclic Zika Virus NS2B-NS3 Protease Inhibitors.
J Med Chem 65: 6555-6572.
Online-Abstract

Jepsen K, Falk W, Brune F, Cosgarea R, Fimmers R, Bekeredjian-Ding I, Jepsen S (2022): Prevalence and Antibiotic Susceptibility Trends of Selected Enterobacteriaceae, Enterococci, and Candida albicans in the Subgingival Microbiota of German Periodontitis Patients: A Retrospective Surveillance Study.
Antibiotics (Basel) 11: 385.
Text

Jia W, Asare E, Liu T, Zhang P, Wang Y, Wang s, Shen D, Miskey C, Gao B, Ivics Z, Qian Q, Song C (2022): Horizontal Transfer and Evolutionary Profiles of Two Tc1/ DD34E Transposons ( ZB and SB) in Vertebrates.
Genes (Basel) 13: 2239.
Text

Jutel M, Torres MJ, Palomares O, Akdis CA, Eiwegger T, Untersmayr E, Barber D, Zemelka-Wiacek M, Kosowska A, Palmer E, Vieths S, Mahler V, Canonica GW, Nadeau K, Shamji MH, Agache I, EAACI Research and Outreach Committee Group (2022): COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals - EAACI recommendations.
Allergy 77: 2313-2336.
Text

Kahnt AS, Angioni C, Göbel T, Hofmann B, Roos J, Steinbrink SD, Rörsch F, Thomas D, Geisslinger G, Zacharowski K, Grösch S, Steinhilber D, Maier TJ (2022): Inhibitors of Human 5-Lipoxygenase Potently Interfere With Prostaglandin Transport.
Front Pharmacol 12: 782584.
Text

Kehr S, Berg P, Müller S, Fiedler SA, Meyer B, Ruppert-Seipp G, Witzenhausen C, Wolf ME, Henkes HH, Oberle D, Keller-Stanislawski B, Funk MB (2022): Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis.
NPJ Vaccines 7: 76.
Online-Abstract

Khaleva E, Rattu A, Brightling C, Bush A, Bossios A, Bourdin A, Chung KF, Chaudhuri R, Coleman C, Dahlén SE, Djukanovic R, Deschildre A, Fleming L, Fowler SJ, Gupta A, Hamelmann E, Hashimoto S, Hedlin G, Koppelman GH, Melén E, Murray CS, Pilette C, Porsbjerg C, Pike KC, Rusconi F, Williams C, Ahrens B, Alter P, Anckers F, van den Berge M, Blumchen K, Brusselle G, Clarke GW, Cunoosamy D, Dahlén B, Dixey P, Exley A, Frey U, Gaillard EA, Giovannini-Chami L, Grigg J, Hartenstein D, Heaney LG, Karadag B, Kaul S, Kull I, Licari A, Maitland-van der Zee AH, Mahler V, Schoos AM, Nagakumar P, Negus J, Nielsen H, Paton J, Pijnenburg M, Ramiconi V, Vilarnau SR, Principe S, Rutjes N, Saglani S, Seddon P, Singer F, Staudinger H, Turner S, Vijverberg S, Winders T, Yasinska V, Roberts G, COMSA working group in the 3TR consortium (2022): Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA).
Eur Respir J 61: 2200606.
Online-Abstract

Kim YJ, Manna D, Etscheid M, Leergaard TB, Kanse SM (2022): Factor VII activating protease (FSAP) inhibits the outcome of ischemic stroke in mouse models.
FASEB J 36: e22564.
Text

Knezevic I, Mattiuzzo G, Page M, Nuebling CM, Griffiths E, Minor P (2022): Complexity of serological assays and misunderstandings of WHO International Units.
Clin Chem Lab Med 60: e223-e224.
Online-Abstract

Knezevic I, Mattiuzzo G, Page M, Minor P, Griffiths E, Nübling CM, Moorthy V (2022): WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific community.
Lancet Microbe 3: e235-e240.
Text

Krauter S, Buescher N, Bräuchle E, Ortega Iannazzo S, Penner I, Krämer N, Gogesch P, Thomas S, Kreutz M, Dejung M, Freiwald A, Butter F, Waibler Z, Plachter B (2022): An Attenuated Strain of Human Cytomegalovirus for the Establishment of a Subviral Particle Vaccine.
Vaccines (Basel) 10: 1326.
Text

Krijnse Locker J (2022): Tips and tricks of viruses; unconventional egress.
Mol Microbiol 117: 1291-1292.
Text

Kropp M, Harmening N, Bascuas T, Johnen S, De Clerck E, Fernández V, Ronchetti M, Cadossi R, Zanini C, Scherman D, Ivics Z, Marie C, Izsvák Z, Thumann G (2022): GMP-Grade Manufacturing and Quality Control of a Non-Virally Engineered Advanced Therapy Medicinal Product for Personalized Treatment of Age-Related Macular Degeneration.
Biomedicines 10: 2777.
Text

Kurki P, Kang HN, Ekman N, Knezevic I, Weise M, Wolff-Holz E (2022): Regulatory Evaluation of Biosimilars: Refinement of Principles Based on the Scientific Evidence and Clinical Experience.
BioDrugs 36: 359-371.
Text

Liu M, Zhou T, Sheets R, Meyer H, Knezevic I (2022): WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20-22 April 2021.
Emerg Microbes Infect 11: 384-391.
Online-Abstract

Lohse S, Sternjakob-Marthaler A, Lagemann P, Schöpe J, Rissland J, Seiwert N, Pfuhl T, Müllendorff A, Kiefer LS, Vogelgesang M, Vella L, Denk K, Vicari J, Zwick A, Lang I, Weber G, Geisel J, Rech J, Schnabel B, Hauptmann G, Holleczek B, Scheiblauer H, Wagenpfeil S, Smola S (2022): German federal-state-wide seroprevalence study of 1st SARS-CoV-2 pandemic wave shows importance of long-term antibody test performance.
Commun Med (Lond) 2: 52.
Text

Mahler V, Junker AC (2022): Anaphylaxie auf Zusatzstoffe in Impfstoffen.
Allergo J 31: 22-39.
Text

Mahler V, Junker AC (2022): Anaphylaxis to additives in vaccines.
Allergo J Int 31: 123-136.
Text

Marx C, Sonnemann J, Maddocks ODK, Marx-Blümel L, Beyer M, Hoelzer D, Thierbach R, Maletzki C, Linnebacher M, Heinzel T, Krämer OH (2022): Global metabolic alterations in colorectal cancer cells during irinotecan-induced DNA replication stress.
Cancer Metab 10: 10.
Text

Mattern L, Otten K, Miskey C, Fuest M, Izsvák Z, Ivics Z, Walter P, Thumann G, Johnen S (2022): Molecular and Functional Characterization of BDNF-Overexpressing Human Retinal Pigment Epithelial Cells Established by Sleeping Beauty Transposon-Mediated Gene Transfer.
Int J Mol Sci 23: 12982.
Text

Mbunkah H, Kafere C, Samukange W, Nübling CM, Reinhardt J (2022): Congress report: Online workshop on assessment of technical files for blood screening in vitro diagnostics for sub-Sahara African countries.
Transfus Med 32: 467-474.
Text

Mentzer D, Keller-Stanislawski B (2022): Verdachtsfälle von Nebenwirkungen und Impfkomplikationen nach Impfung mit Comirnaty® bei Kindern im Alter von 5–11 Jahren aus Deutschland: Meldungen an das Paul-Ehrlich-Institut bis zum 03.03.2022.
Bulletin zur Arzneimittelsicherheit 13: 15-21.
Text

Mentzer D, Keller-Stanislawski B (2022): Verdachtsfälle von Nebenwirkungen oder Impfkomplikationen nach Impfung mit den Omikron-adaptierten bivalenten COVID-19-Impfstoffen Comirnaty Original/Omicron BA.1, Comirnaty Original/Omicron BA.4-5, Spikevax bivalent/ Omicron BA.1 (bis 31.10.2022 in Deutschland gemeldet).
Bulletin zur Arzneimittelsicherheit 13: 29-34.
Text

Michaleas S, Moreno Oliver A, Mueller-Berghaus J, Sarac SB, van der Elst ME, Müller-Egert S, Zander H, Enzmann H, Pignatti F (2022): The European Medicines Agency review of sacituzumab govitecan for the treatment of triple-negative breast cancer.
ESMO Open 7: 100497.
Online-Abstract

Michels A, Ho N, Buchholz CJ (2022): Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platforms.
Mol Ther 30: 2401-2415.
Text

Miller L, Waibler Z, Regourd E, Jouette S (2022): Collaborative study for the establishment of Human immunoglobulin for anticomplementary activity BRP replacement batches 3, 4, 5 and 6.
Pharmeur Bio Sci Notes 2022: 10-21.
Online-Abstract

Miranda-García MA, Hoffelner M, Stoll H, Ruhaltinger D, Cichutek K, Siedler A, Bekeredjian-Ding I (2022): A 5-year look-back at the notification and management of vaccine supply shortages in Germany.
Euro Surveill 27: 2100167.
Text

Miskey C, Botezatu L, Temiz NA, Gogol-Doring A, Bartha A, Gyorffy B, Largaespada DA, Ivics Z, Sebe A (2022): In Vitro Insertional Mutagenesis Screen Identifies Novel Genes Driving Breast Cancer Metastasis.
Mol Cancer Res 20: 1502-1515.
Online-Abstract

Miskey C, Kesselring L, Querques I, Abrusán G, Barabas O, Ivics Z (2022): Engineered Sleeping Beauty transposase redirects transposon integration away from genes.
Nucleic Acids Res 50: 2807-2825.
Text

Mitterreiter J, Scheiblauer H, Fiedler S, Kreß J (2022): Sicherheit von Blut und Blutprodukten: Testmethoden zum Nachweis der Hepatitisviren B, C und E.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65: 209-219.
Text

Mönch K, Streit R, Keller-Stanislawski B (2022): Nuvaxovid® – gemeldete Verdachtsfälle von Nebenwirkungen in den ersten drei Monaten seit Beginn der Impfungen mit diesem Impfstoff.
Bulletin zur Arzneimittelsicherheit 13: 27-30.
Text

Owusu Sekyere S, Škrnjug-Yudov I, Ateba Ngoa U, Juárez Hernández M, Abiri OT, Komeh JP, Janneh Kaira M, Marenah E, Kercula JD, Smith K, Rassokhina O, Meyer H, Conrad C (2022): Leveraging WHO's Global Benchmarking Tool to strengthen capacity in clinical trials oversight for public health emergencies: the GHPP VaccTrain model.
Global Health 18: 63.
Text

Owusu Sekyere S, Škrnjug-Yudov I, Pinz A, Meyer H, Conrad C (2022): The Pivotal Role of Quality Technical Structures for Clinical Trials Oversight in the Achievement of Long-Term Capacity Strengthening Outcomes.
Front Med (Lausanne) 9: 772605.
Text

Peng R, Wang CK, Wang-Kan X, Idorn M, Kjaer M, Zhou FY, Fiil BK, Timmermann F, Orozco SL, McCarthy J, Leung CS, Lu X, Bagola K, Rehwinkel J, Oberst A, Maelfait J, Paludan SR, Gyrd-Hansen M (2022): Human ZBP1 induces cell death-independent inflammatory signaling via RIPK3 and RIPK1.
EMBO Rep 23: e55839.
Online-Abstract

Poulsen LK, Patil S, Vieths S, van Ree R: Immunotherapy and molecular allergy approaches.
In: Hoffmann-Sommergruber K, Hilger C, Santos A, de las Vecillas L, Dramburg S / EAACI (Hrsg.), Molecular Allergology User’s Guide 2.0: John Wiley & Sons Ltd., 2022. S. 121-133, ISBN 978-3-9524815-4-7

Prommersberger S, Monjezi R, Botezatu L, Miskey C, Amberger M, Mestermann K, Hudecek M, Ivics Z: Generation of CAR-T Cells with Sleeping Beauty Transposon Gene Transfer.
In: Walter W (Hrsg.), Gene Therapy of Cancer: Humana Press, 2022. S. 41-66, ISBN 978-1-0716-2440-1
(Methods in Molecular Biology 2521)

Prommersberger S, Monjezi R, Shankar R, Schmeer M, Hudecek M, Ivics Z, Schleef M: Minicircles for CAR T Cell Production by Sleeping Beauty Transposition: A Technological Overview.
In: Walter W (Hrsg.), Gene Therapy of Cancer: Humana Press, 2022. S. 25-39, ISBN 978-1-0716-2440-1
(Methods in Molecular Biology 2521)

Rahbar S, Shafiekhani S, Allahverdi A, Jamali A, Kheshtchin N, Ajami M, Mirsanei Z, Habibi S, Makkiabadi B, Hadjati J, Jafari AH (2022): Agent-based Modeling of Tumor and Immune System Interactions in Combinational Therapy with Low-dose 5-fluorouracil and Dendritic Cell Vaccine in Melanoma B16F10.
Iran J Allergy Asthma Immunol 21: 151-166.
Online-Abstract

Reichart B, Cooper DKC, Längin M, Tönjes RR, Pierson III RN, Wolf E (2022): Cardiac xenotransplantation: From concept to clinic.
Cardiovasc Res 118: 3499-3516.
Text

Reinecke B, Frericks N, Lauber C, Dinkelborg K, Matthaei A, Vondran FWR, Behrendt P, Haid S, Brown RJP, Pietschmann T (2022): The Human Liver-Expressed Lectin CD302 Restricts Hepatitis C Virus Infection.
J Virol 96: e01995-21.
Text

Reitz S, Schwantes A (2022): Proceedings of 2019 Viral Clearance Symposium, Session 1: Viral Clearance Strategies and Case Studies.
PDA J Pharm Sci Technol 76: 297-305.
Online-Abstract

Robertson JS, Loizides U, Adisa A, López de la Rica Manjavacas A, Rodilla V, Strnadova C, Weisser K, Balocco R (2022): International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety.
Vaccine 40: 21-27.
Online-Abstract

Rodriguez-Rodriguez N, Clark PA, Gogoi M, Ferreira ACF, Kerscher B, Crisp A, Jolin HE, Murphy JE, Sivasubramaniam M, Pedro L, Walker JA, Heycock MWD, Shields JD, Barlow JL, McKenzie ANJ (2022): Identification of aceNKPs, a committed common progenitor population of the ILC1 and NK cell continuum.
Proc Natl Acad Sci USA 119: e2203454119.
Text

Roig MB, Krotka P, Burman CF, Glimm E, Gold SM, Hees K, Jacko P, Koenig F, Magirr D, Mesenbrink P, Viele K, Posch M (2022): On model-based time trend adjustments in platform trials with non-concurrent controls.
BMC Med Res Methodol 22: 228.
Text

Rommel MGE, Walz L, Fotopoulou F, Kohlscheen S, Schenk F, Miskey C, Botezatu L, Krebs Y, Voelker IM, Wittwer K, Holland-Letz T, Ivics Z, von Messling V, Essers MAG, Milsom MD, Pfaller CK, Modlich U (2022): Influenza A Virus Infection Instructs Hematopoiesis to Megakaryocyte-lineage Output.
Cell Rep 41: 111447.
Online-Abstract

Roush D, Blümel J (2022): Proceedings of 2019 Viral Clearance Symposium, Session 4: Viral Clearance Strategy and Process Understanding.
PDA J Pharm Sci Technol 76: 323-338.
Online-Abstract

Savage AL, Iacoangeli A, Schumann GG, Rubio-Roldan A, Garcia-Perez JL, Al Khleifat A, Koks S, Bubb VJ, Al-Chalabi A, Quinn JP (2022): Characterisation of retrotransposon insertion polymorphisms in whole genome sequencing data from individuals with amyotrophic lateral sclerosis.
Gene 843: 146799.
Online-Abstract

Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C (2022): Antibody response to SARS-CoV-2 for more than one year − kinetics and persistence of detection are predominantly determined by avidity progression and test design.
J Clin Virol 146: 105052.
Text

Schmidt C, Haefner E, Gerbeth J, Beissert T, Sahin U, Perkovic M, Schnierle BS (2022): A taRNA vaccine candidate induces a specific immune response that protects mice against Chikungunya virus infections.
Mol Ther Nucleic Acids 28: 743-754.
Text

Schmidt C, Hastert FD, Gerbeth J, Beissert T, Sahin U, Perkovic M, Schnierle BS (2022): A Bivalent Trans-Amplifying RNA Vaccine Candidate Induces Potent Chikungunya and Ross River Virus Specific Immune Responses.
Vaccines (Basel) 10: 1374.
Text

Schmidt C, Schnierle BS (2022): Chikungunya Vaccine Candidates: Current Landscape and Future Prospects.
Drug Des Devel Ther 16: 3663-3673.
Online-Abstract

Schnierle BS (2022): Monkeypox Goes North: Ongoing Worldwide Monkeypox Infections in Humans.
Viruses 14: 1874.
Text

Schott K, Majer C, Bulashevska A, Childs L, Schmidt MHH, Rajalingam K, Munder M, König R (2022): SAMHD1 in cancer: curse or cure?.
J Mol Med (Berl) 100: 351-372.
Online-Abstract

Schüßler-Lenz M, Scherer J, Müller-Berghaus J (2022): Arzneimittel für neuartige Therapien (ATMP): Ankunft in der Versorgung.
Pharmakon 10: 337-343.
Text

Schwarz R, Zitzow E, Fiebig A, Hering S, Humboldt Y, Schoenwaelder N, Kämpfer N, Volkmar K, Hinz B, Kreikemeyer B, Maletzki C, Fiedler T (2022): PEGylation increases antitumoral activity of arginine deiminase of Streptococcus pyogenes.
Appl Microbiol Biotechnol 106: 261-271.
Online-Abstract

Sediri-Schön H, Lange J, Grabski E, Wagner R, Hildt E (2022): Chargenprüfung als wesentliche Säule der Versorgung mit sicheren und wirksamen Impfstoffen.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65: 1244-1250.
Text

Shin DL, Chludzinski E, Wu NH, Peng JY, Ciurkiewicz M, Sawatsky B, Pfaller CK, Baechlein C, von Messling V, Haas L, Beineke A, Herrler G (2022): Overcoming the Barrier of the Respiratory Epithelium during Canine Distemper Virus Infection.
mBio 13: e0304321.
Online-Abstract

Siering O, Cattaneo R, Pfaller CK (2022): C Proteins: Controllers of Orderly Paramyxovirus Replication and of the Innate Immune Response.
Viruses 14: 137.
Online-Abstract

Specht R, Schwantes A (2022): Proceedings of 2019 Viral Clearance Symposium, Session 2: New Modalities in Chromatography and Adsorptive Filters.
PDA J Pharm Sci Technol 76: 306-314.
Online-Abstract

Steigerwald H, Blanco-Perez F, Albrecht M, Bender C, Wangorsch A, Endreß HU, Bunzel M, Mayorga C, Torres MJ, Scheurer S, Vieths S (2022): Does the Food Ingredient Pectin Provide a Risk for Patients Allergic to Non-Specific Lipid-Transfer Proteins?.
Foods 11: 13.
Online-Abstract

Strecker MI, Wlotzka K, Strassheimer F, Roller B, Ludmirski G, König S, Röder J, Opitz C, Alekseeva T, Reul J, Sevenich L, Tonn T, Wels WS, Steinbach JP, Buchholz CJ, Burger MC (2022): AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma.
Oncoimmunology 11: e2127508.
Text

Thibau A, Vaca DJ, Bagowski M, Hipp K, Bender D, Ballhorn W, Linke D, Kempf VAJ (2022): Adhesion of Bartonella henselae to Fibronectin Is Mediated via Repetitive Motifs Present in the Stalk of Bartonella Adhesin A.
Microbiol Spectr 10: e02117-22.
Text

Thiele T, Weisser K, Schönborn L, Funk MB, Weber G, Greinacher A, Keller-Stanislawski K (2022): Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany.
Lancet Reg Health Eur 12: 100270.
Online-Abstract

Tonnemacher S, Folly-Klan M, Gazi AD, Schäfer S, Pénard E, Eberle R, Kunz R, Walther P, Krijnse Locker J (2022): Vaccinia virus H7-protein is required for the organization of the viral scaffold protein into hexamers.
Sci Rep 12: 13007.
Text

Wachtl G, Schád É, Huszár K, Palazzo A, Ivics Z, Tantos Á, Orbán TI (2022): Functional Characterization of the N-Terminal Disordered Region of the piggyBac Transposase.
Int J Mol Sci 23: 10317.
Text

Wadhwa M, Kang HN, Thorpe R, Knezevic I, following participants of the WHO informal consultation on revision of guidelines on evaluation of similar biotherapeutic products, Aprea P, Bielsky MC, Ekman N, Heim HK, Joung J, Kurki P, Lacana E, Njue C, Nkansah E, Savkina M, Thorpe R, Yamaguchi T, Wadhwa M, Wang J, Weise M, Wolff-Holz E, other participants: Representatives of the Developing Countries Vaccine Manufacturers Network; Representatives of the Emerging Biopharmaceutical Manufacturers Network; Representatives of the IFPMA; Representatives of IGBA; Representative of the Latin American Association of Pharmaceutical Industries; Representative of the Singapore Association of Pharmaceutical Industries; WHO Secretariat (2022): WHO informal consultation on revision of guidelines on evaluation of similar biotherapeutic products, virtual meeting, 30 June - 2 July 2021.
Biologicals 76: 1-9.
Online-Abstract

Wagner R, Meißner J, Grabski E, Sun Y, Vieths S, Hildt E (2022): Regulatory concepts to guide and promote the accelerated but safe clinical development and licensure of COVID-19 vaccines in Europe.
Allergy 77: 72-82.
Online-Abstract

Wangorsch A, Lidholm J, Mattsson LA, Larsson H, Reuter A, Gubesch M, Gadermaier G, Bures P, Scheurer S, Ballmer-Weber B, Vieths S (2022): Identification of a defensin as novel allergen in celery root: Api g 7 as a missing link in the diagnosis of celery allergy?.
Allergy 77: 1294-1296.
Online-Abstract

Wangorsch A, Scheurer S, Blanca M, Blanca-Lopez N, Somoza ML, Martin-Pedraza L (2022): Allergenic Properties and Molecular Characteristics of PR-1 Proteins.
Front Allergy 3: 824717.
Text

Weisser K (2022): Abschied von „-mab“– neue internationale Freinamen (INN) für monoklonale Antikörper.
Bulletin zur Arzneimittelsicherheit 13: 31-35.
Text

Wenzel A, Thomas J, Schwedinger E, Wolf R (2022): Pharmakovigilanzreport immunologischer Tierarzneimittel: Analyse der Meldungen unerwünschter Ereignisse in Deutschland aus dem Jahr 2021.
DTBl 70: 1166-1174.
Volltext

Wöhrle F, Kerscher B, Cicin-Sain L, Bekeredjian-Ding I (2022): DGfI Study Group Vaccines - Annual Meeting 2022.
Eur J Immunol 52: 370-371.
Text

Woods VMA, Latorre-Rey LJ, Schenk F, Rommel MGE, Moritz T, Modlich U (2022): Targeting transgenic proteins to alpha granules for platelet-directed gene therapy.
Mol Ther Nucleic Acids 27: 774-786.
Text

Worm M, Vieths S, Mahler V (2022): An update on anaphylaxis and urticaria.
J Allergy Clin Immunol 150: 1265-1278.
Text

Yoh SM, Mamede JI, Lau D, Ahn N, Sánchez-Aparicio MT, Temple J, Tuckwell A, Fuchs NV, Cianci GC, Riva L, Curry H, Yin X, Gambut S, Simons LM, Hultquist JF, König R, Xiong Y, García-Sastre A, Böcking T, Hope TJ, Chanda SK (2022): Recognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nascent HIV-1 DNA.
Mol Cell 82: 2871-2884.e6.
Online-Abstract

Zahn T, Mhedhbi I, Hein S, Raupach J, Miskey C, Husria Y, Bayanga K, Bartel D, Vieths S, Ivics Z, Oberle D, Keller-Stanislawski K, Herrlein ML, Maier TJ, Hildt E (2022): Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19.
Allergy 77: 2053-2066.
Online-Abstract

Zimmer J, Schmidt S, Costanzo A, Buchheit KH, Brown S, Carnés J, Chapman M, Chen A, De Neergaard M, Döring S, Hindley J, Holzhauser T, Jorajuria S, Le Tallec D, Lombardero M, Iacovacci P, Reese G, Sander I, Smith B, Strecker D, van Ree R, Zebina M, Kaul S, Vieths S (2022): Validation of an ELISA method for quantification of the major Timothy grass pollen allergen Phl p 5a (BSP090).
Pharmeur Bio Sci Notes 2022: 55-86.
Online-Abstract

Zimmer J, Schmidt S, Klos J, Döring S, Strecker D, Vieths S, Kaul S (2022): The method makes the extract: Comparative analysis of birch pollen allergen extracts.
Clin Exp Allergy 52: 784-787.
Text

Zimmermann J, Goretzki A, Meier C, Wolfheimer S, Lin YJ, Rainer H, Krause M, Wedel S, Spies G, Führer F, Vieths S, Scheurer S, Schülke S (2022): Modulation of dendritic cell metabolism by an MPLA-adjuvanted allergen product for specific immunotherapy.
Front Immunol 13: 916491.
Text

Aganovic K, Hertel C, Vogel RF, Johne R, Schlüter O, Schwarzenbolz U, Jäger H, Holzhauser T, Bergmair J, Roth A, Sevenich R, Bandick N, Kulling SE, Knorr D, Engel KH, Heinz V (2021): Aspects of high hydrostatic pressure food processing: Perspectives on technology and food safety.
Compr Rev Food Sci Food Saf 20: 3225-3266.
Online-Abstract

Albinger N, Hartmann J, Ullrich E (2021): Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany.
Gene Ther 28: 513-527.
Text

Albrecht M (2021): Turning off the alarm - Targeting alarmins and other epithelial mediators of allergic inflammation with biologics.
Allergol Select 9: 82-88.
Text

Ansah JK, Kafere C, Loua A, Nkansah E, Acquah ME, Mudyiwenyama L (2021): Regulation of blood services in Africa.
Transfus Clin Biol 28: 148-153.
Online-Abstract

Anzaghe M, Kronhart S, Niles MA, Höcker L, Dominguez M, Kochs G, Waibler Z (2021): Type I interferon receptor-independent interferon-α induction upon infection with a variety of negative-strand RNA viruses.
J Gen Virol 102: 001616.
Text

Araujo-Fernandez I, Delgado J, Moscetti L, Sarac SB, Zander H, Müller-Egert S, Dunder K, Pean E, Bergmann L, Enzmann H, Pignatti F (2021): The European Medicines Agency review of the initial application of atezolizumab and the role of PD-L1 expression as biomarker for checkpoint inhibitors.
ESMO Open 6: 100008.
Online-Abstract

Basic M, Kubesch A, Kuhnhenn L, Görgülü E, Finkelmeier F, Dietz J, Knabe M, Mücke VT, Mücke MM, Berger A, Zeuzem S, Sarrazin C, Hildt E, Peiffer KH (2021): Not uncommon: HBV genotype G co-infections among healthy European HBV carriers with genotype A and E infection.
Liver Int 41: 1278-1289.
Online-Abstract

Baylis S, Nübling CM, Dimech W: Standardization of diagnostic assays.
In: Bamford DH, Zuckerman M (Hrsg.), Encyclopedia of Virology (Fourth Edition): Academic Press, 2021. S. 52-63, ISBN 978-0-12-814516-6

Baylis SA, Nübling CM (2021): Nucleic Acid Testing of Viral Pathogens: Traceability of the International Unit.
Clin Chem 68: 257-258.
Text

Bitar L, Schumann U, König R, Zipp F, Schmidt MHH (2021): Targeting Immune Modulators in Glioma While Avoiding Autoimmune Conditions.
Cancers (Basel) 13: 3524.
Online-Abstract

Blanco-Pérez F, Steigerwald H, Schülke S, Vieths S, Toda M, Scheurer S (2021): The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota.
Curr Allergy Asthma Rep 21: 43.
Text

Bousquet J, Agache I, Blain H, Jutel M, Ventura MT, Worm M, Del Giacco S, Benetos A, Bilo MB, Czarlewski W, Abdul Latiff AH, Al-Ahmad M, Angier E, Annesi-Maesano I, Atanaskovic-Markovic M, Bachert C, Barbaud A, Bedbrook A, Bennoor KS, Berghea EC, Bindslev-Jensen C, Bonini S, Bosnic-Anticevich S, Brockow K, Brussino L, Camargos P, Canonica GW, Cardona V, Carreiro-Martins P, Carriazo A, Casale T, Caubet JC, Cecchi L, Cherubini A, Christoff G, Chu DK, Cruz AA, Dokic D, El-Gamal Y, Ebisawa M, Eberlein B, Farrell J, Fernandez-Rivas M, Fokkens WJ , Fonseca JA, Gao Y, Gavazzi G, Gawlik R, Gelincik A , Gemicioğlu B, Gotua M, Guérin O, Haahtela T, Hoffmann-Sommergruber K, Hoffmann HJ, Hofmann M, Hrubisko M, lenaIllario M, Irani C, Ispayeva Z, Ivancevich JC, Julge K, Kaidashev I, Khaitov M, Knol E, Kraxner H, Kuna P, Kvedariene V, Lauerma A, Le LT, Le Moing V, Levin M, Louis R, Lourenco O, Mahler V, Martin FC, Matucci A, Milenkovic B, Miot S, Montella E, Morais-Almeida M, Mortz CG, Mullol J, Namazova-Baranova L, Neffen H, Nekam K, Niedoszytko M, Odemyr M, O'Hehir RE, Okamoto Y, Ollert M, Palomares O, Papadopoulos NG, Panzner P, Passalacqua G, Patella V, Petrovic M, Pfaar O, Pham-Thi N, Plavec D, Popov TA, Recto MT, Regateiro FS, Reynes J , Roller-Winsberger RE, Rolland Y, Romano A, Rondon C, Rottem M, Rouadi PW, Salles N, Samolinski B, Santos AF, Serpa FS, Sastre J, Schols JMGA, Scichilone N, Sediva A, Shamji MH, Sheikh A, Skypala I, Smolinska S, Sokolowska M, Sousa-Pinto B, Sova M, Stelmach R, Sturm G, Suppli Ulrik C, Todo-Bom AM, Toppila-Salmi S, Tsiligianni I, Torres M, Untersmayr E, Urrutia Pereira M, Valiulis A, Vitte J, Vultaggio A, Wallace D, Walusiak-Skorupa J, Wang DY , Waserman S, Yorgancioglu A, Yusuf OM, Zernotti M, Zidarn M, Chivato T, Akdis CA, Zuberbier T, Klimek L (2021): Management of anaphylaxis due to COVID-19 vaccines in the elderly.
Allergy 76: 2952-2964.
Online-Abstract

Büning H, Fehse B, Ivics Z, Kochanek S, Koehl U, Kupatt C, Mussolino C, Nettelbeck DM, Schambach A, Uckert W, Wagner E, Cathomen T (2021): Gene Therapy "Made in Germany": A Historical Perspective, Analysis of the Status Quo, and Recommendations for Action by the German Society for Gene Therapy.
Hum Gene Ther 32: 987-996.
Online-Abstract

Bueno-Díaz C, Martín-Pedraza L, Parrón J, Cuesta-Herranz J, Cabanillas B, Pastor-Vargas C, Batanero E, Villalba M (2021): Characterization of Relevant Biomarkers for the Diagnosis of Food Allergies: An Overview of the 2S Albumin Family.
Foods 10: 1235.
Text

Canet-Pons J, Sen NE, Arsovíc A, Almaguer-Mederos LE, Halbach MV, Key J, Döring C, Kerksiek A, Picchiarelli G, Cassel R, René F, Dieterlé S, Fuchs NV, König R, Dupuis L, Lütjohann D, Gispert S, Auburger G (2021): Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression.
Neurobiol Dis 152: 105289.
Text

Chansard A, Dubrulle N, Poujol de Molliens M, Falanga PB, Stephen T, Hasan M, van Zandbergen G, Aulner N, Shorte SL, David-Watine B, Milieu Intérieur Consortium (2021): Corrigendum: Unveiling Interindividual Variability of Human Fibroblast Innate Immune Response Using Robust Cell-Based Protocols.
Front Immunol 12: 685768.
Text

Chansard A, Dubrulle N, Poujol de Molliens M, Falanga PB, Stephen T, Hasan M, van Zandbergen G, Aulner N, Shorte SL, David-Watine B (2021): Unveiling Interindividual Variability of Human Fibroblast Innate Immune Response Using Robust Cell-Based Protocols.
Front Immunol 11: 569331.
Text

Chanyalew M, Abebe M, Endale B, Girma S, Tasew G, Bobosha K, Zewide M, Howe R, van Zandbergen G, Ritter U, Gadisa E, Aseffa A, Laskay T (2021): Enhanced activation of blood neutrophils and monocytes in patients with Ethiopian localized cutaneous leishmaniasis in response to Leishmania aethiopica Neutrophil activation in Ethiopian cutaneous leishmaniasis.
Acta Trop 220: 105967.
Online-Abstract

Chanyalew M, Abebe M, Endale B, Girma S, Tasew G, van Zandbergen G, Ritter U, Gadisa E, Aseffa A, Laskay T (2021): Enhanced production of pro-inflammatory cytokines and chemokines in Ethiopian cutaneous leishmaniasis upon exposure to Leishmania aethiopica.
Cytokine 145: 155289.
Online-Abstract

Charitidis FT, Adabi E, Thalheimer FB, Clarke C, Buchholz CJ (2021): Monitoring CAR T cell generation with a CD8-targeted lentiviral vector by single-cell transcriptomics.
Mol Ther Methods Clin Dev 23: 359-369.
Online-Abstract

Cheng TY, Lin YJ, Saburi W, Vieths S, Scheurer S, Schülke S, Toda M (2021): β-(1→4)-Mannobiose Acts as an Immunostimulatory Molecule in Murine Dendritic Cells by Binding the TLR4/MD-2 Complex.
Cells 10: 1774.
Text

Correia Pinheiro L, Giezen TJ, Wolff-Holz E, Weise M, Laslop A, Hidalgo-Simon A (2021): Identifiability of Biologicals: An Analysis Using EudraVigilance, the European Union's Database of Reports of Suspected Adverse Drug Reactions.
Clin Pharmacol Ther 110: 1311-1317.
Text

Costa J, Villa C, Verhoeckx K, Cirkovic-Velickovic T, Schrama D, Roncada P, Rodrigues PM, Piras C, Martín-Pedraza L, Monaci L, Molina E, Mazzucchelli G, Mafra I, Lupi R, Lozano-Ojalvo D, Larré C, Klueber J, Gelencser E, Bueno-Diaz C, Diaz-Perales A, Benedé S, Bavaro SL, Kuehn A, Hoffmann-Sommergruber K, Holzhauser T (2021): Are Physicochemical Properties Shaping the Allergenic Potency of Animal Allergens?.
Clin Rev Allergy Immunol 62: 1-36.
Online-Abstract

Datema MR, Lyons SA, Fernández-Rivas M, Ballmer-Weber B, Knulst AC, Asero R, Barreales L, Belohlavkova S, de Blay F, Clausen M, Dubakiene R, Fernández-Perez C, Fritsche P, Gislason D, Hoffmann-Sommergruber K, Jedrzejczak-Czechowicz M, Jongejan L, Kowalski ML, Kralimarkova TZ, Lidholm J, Papadopoulos NG, Popov TA, del Prado N, Purohit A, Reig I, Seneviratne SL, Sinaniotis A, Vassilopoulou E, Versteeg SA, Vieths S, Welsing PMJ, Mills ENC, Le TM, Zwinderman AH, van Ree R (2021): Estimating the Risk of Severe Peanut Allergy Using Clinical Background and IgE Sensitization Profiles.
Front Allergy 2: 670789.
Text

Davis CA, Haywood B, Vattipally S, Da Silva Filipe A, AlSaeed M, Smollet K, Baylis SA, Ijaz S, Tedder RS, Thomson EC, Abdelrahman TT (2021): Hepatitis E virus: Whole genome sequencing as a new tool for understanding HEV epidemiology and phenotypes.
J Clin Virol 139: 104738.
Online-Abstract

de Alwis R, Zellweger RM, Chua E, Wang LF, Chawla T, Sessions OM, Marlier D, Connolly JE, von Messling V, Anderson DE (2021): Systemic inflammation, innate immunity and pathogenesis after Zika virus infection in cynomolgus macaques are modulated by strain-specificity within the Asian lineage.
Emerg Microbes Infect 10: 1457-1470.
Online-Abstract

De Marchi L, Mainente F, Leonardi M, Scheurer S, Wangorsch A, Mahler V, Pilolli R, Sorio D, Zoccatelli G (2021): Allergenicity assessment of the edible cricket Acheta domesticus in terms of thermal and gastrointestinal processing and IgE cross-reactivity with shrimp.
Food Chem 359: 129878.
Online-Abstract

De Marchi L, Wangorsch A, Zoccatelli G (2021): Allergens from Edible Insects: Cross-reactivity and Effects of Processing.
Curr Allergy Asthma Rep 21: 35.
Online-Abstract

Dickel H, Kuehn A, Dickel B, Bauer A, Becker D, Fartasch M, Haeberle M, John SM, Mahler V, Skudlik C, Weisshaar E, Werfel T, Geier J, Diepgen TL (2021): Assessment of the effects of a work-related allergy to seafood on the reduction of earning capacity in the context of BK No. 5101.
Allergol Select 5: 33-44.
Online-Abstract

Droste A, Chaves G, Stein S, Trzmiel A, Schweizer M, Karl H, Musset B (2021): Zinc accelerates respiratory burst termination in human PMN.
Redox Biol 47: 102133.
Text

Eichler H, Feyer AK, Weitmann K, Hoffmann W, Henseler O, Opitz A, Patek A, Hans DN, Schönborn L, Greinacher A (2021): Population-Based Analysis of the Impact of Demographics on the Current and Future Blood Supply in the Saarland.
Transfus Med Hemother 48: 175-182.
Text

Englert L, Mahler V, Bonertz A (2021): Regulatory Requirements for the Quality of Allergen Products for Allergen Immunotherapy of Food Allergy.
Curr Allergy Asthma Rep 21: 32.
Text

Etna MP, Signorazzi A, Ricci D, Severa M, Rizzo F, Giacomini E, Gaggioli A, Bekeredjian-Ding I, Huckriede A, Coccia EM (2021): Human plasmacytoid dendritic cells at the crossroad of type I interferon-regulated B cell differentiation and antiviral response to tick-borne encephalitis virus.
PLoS Pathog 17: e1009505.
Online-Abstract

Fiack S, Koch-Gromus U, Kuhn J, Lübbing-Raukohl C (2021): Medizin und Medien - Symbiose oder Konflikt?.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 64: 1-2.
Text

Forkel S, Cevik N, Schill T, Worm M, Mahler V, Weisshaar E, Vieluf D, Pfützner W, Löffler H, Schön MP, Geier J, Buhl T (2021): Atopische Hautdiathese ist stärker mit spezifischen Kontaktallergien assoziiert als atopische Dermatitis.
J Dtsch Dermatol Ges 19: 231-240.
Online-Abstract

Fukuda S, Narendran S, Varshney A, Nagasaka Y, Wang SB, Ambati K, Apicella I, Pereira F, Fowler BJ, Yasuma T, Hirahara S, Yasuma R, Huang P, Yerramothu P, Makin RD, Wang M, Baker KL, Marion KM, Huang X, Baghdasaryan E, Ambati M, Ambati VL, Banerjee D, Bonilha VL, Tolstonog GV, Held U, Ogura Y, Terasaki H, Oshika T, Bhattarai D, Kim KB, Feldman SH, Aguirre JI, Hinton DR, Kerur N, Sadda SR, Schumann GG, Gelfand BD, Ambati J (2021): Alu complementary DNA is enriched in atrophic macular degeneration and triggers retinal pigmented epithelium toxicity via cytosolic innate immunity.
Sci Adv 7: eabj3658.
Online-Abstract

Fukuda S, Varshney A, Fowler BJ, Wang S, Narendran S, Ambati K, Yasuma T, Magagnoli J, Leung H, Hirahara S, Nagasaka Y, Yasuma R, Apicella I, Pereira F, Makin RD, Magner E, Liu X, Sun J, Wang M, Baker K, Marion KM, Huang X, Baghdasaryan E, Ambati M, Ambati VL, Pandey A, Pandya L, Cummings T, Banerjee D, Huang P, Yerramothu P, Tolstonog GV, Held U, Erwin JA, Paquola ACM, Herdy JR, Ogura Y, Terasaki H, Oshika T, Darwish S, Singh R, Mozaffari S, Bhattarai D, Kim KY, Hardin JW, Bennett CL, Hinton DR, Hanson TE, Röver C, Parang K, Kerur N, Liu J, Werner BC, Sutton SC, Sadda SR, Schumann GG, Gelfand BD, Gage FH, Ambati J (2021): Cytoplasmic synthesis of endogenous Alu complementary DNA via reverse transcription and implications in age-related macular degeneration.
Proc Natl Acad Sci U S A 118: e2022751118.
Text

Glitscher M, Martín DH, Woytinek K, Schmidt B, Tabari D, Scholl C, Stingl JC, Seelow E, Choi M, Hildt E (2021): Targeting cholesterol metabolism as efficient antiviral strategy against the Hepatitis E virus.
Cell Mol Gastroenterol Hepatol 12: 159-180.
Online-Abstract

Glitscher M, Hildt E (2021): Hepatitis E virus egress and beyond - the manifold roles of the viral ORF3 protein.
Cell Microbiol 23: e13379.
Online-Abstract

Glitscher M, Hildt E (2021): Endosomal Cholesterol in Viral Infections - A Common Denominator?.
Front Physiol 12: 750544.
Text

Glitscher M, Himmelsbach K, Woytinek K, Schollmeier A, Johne R, Praefcke GJK, Hildt E (2021): Identification of the interferon-inducible GTPase GBP1 as major restriction factor for the Hepatitis E virus.
J Virol 95: e01564-20.
Online-Abstract

Gogesch P, Dudek S, van Zandbergen G, Waibler Z, Anzaghe M (2021): The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies.
Int J Mol Sci 22: 8947.
Text

Gonzalez-Klein Z, Cuevas-Zuviria B, Hernandez-Ramirez G, Wangorsch A, Pazos-Castro D, Romero-Sahagun A, Pacios LF, Tome-Amat J, Scheurer S, Diaz-Perales A, Garrido-Arandia M (2021): The key to the allergenicity of lipid transfer protein (LTP) ligands: A structural characterization.
Biochim Biophys Acta Mol Cell Biol Lipids 1866: 158928.
Online-Abstract

Goretzki A, Lin YJ, Schülke S (2021): Immune metabolism in allergies, does it matter? ‐ A review of immune metabolic basics and adaptations associated with the activation of innate immune cells in allergy.
Allergy 76: 3314-3331.
Online-Abstract

Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S (2021): Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
N Engl J Med 384: 2092-2101.
Text

Guerrouahen B, Elnaggar M, Al-Mohannadi A, Kizhakayil D, Bonini C, Benjamin R, Brentjens R, Buchholz CJ, Casorati G, Ferrone S, Locke FL, Martin F, Schambach A, Turtle C, Veys P, van der Vliet HJ, Maccalli C, EICCI Faculty Group (2021): Proceedings From the First International Workshop at Sidra Medicine: "Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development", 15 th-16 th February 2019, Doha, Qatar.
Front Immunol 11: 589381.
Text

Gürtler L, Seitz R, Schramm W (2021): Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine?.
Infection 49: 1071–1074.
Text

Guth S, Hüser S, Roth A, Degen G, Diel P, Edlund K, Eisenbrand G, Engel KH, Epe B, Grune T, Heinz V, Henle T, Humpf HU, Jäger H, Joost HG, Kulling SE, Lampen A, Mally A, Marchan R, Marko D, Mühle E, Nitsche MA, Röhrdanz E, Stadler R, van Thriel C, Vieths S, Vogel RF, Wascher E, Watzl C, Nöthlings U, Hengstler JG (2021): Contribution to the ongoing discussion on fluoride toxicity.
Arch Toxicol 95: 2571-2587.
Online-Abstract

Hassan M, Krieg SC, Ndefo Nde C, Roos J, Maier TJ, El Rady EA, Raslan MA, Sadek KU, Manolikakes G (2021): Streamlined One-Pot Synthesis of Nitro Fatty Acids.
Eur JOC 2021: 2239-2252.
Text

Hein S, Benz NI, Eisert J, Herrlein ML, Oberle D, Dreher M, Stingl JC, Hildt C, Hildt E (2021): Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes.
Vaccines (Basel) 9: 1419.
Online-Abstract

Heinzerling L, La Rosée P, Gutzmer R, Kramer R, Keller-Stanislawski B, Zierold S, Mentzer D (2021): Response to letter entitled: 'Re: Hematological immune related adverse events after treatment with immune checkpoint inhibitors.
Eur J Cancer 153: 272-273.

Hellmuth N, Brat C, Awad O, George S, Kahnt A, Bauer T, Huynh Phuoc HP, Steinhilber D, Angioni C, Hassan M, Hock KJ, Manolikakes G, Zacharowski K, Roos J, Maier TJ (2021): Structural Modifications Yield Novel Insights Into the Intriguing Pharmacodynamic Potential of Anti-inflammatory Nitro-Fatty Acids.
Front Pharmacol 12: 715076.
Text

Hennrich AA, Sawatsky B, Santos-Mandujano R, Banda DH, Oberhuber M, Schopf A, Pfaffinger V, Wittwer K, Riedel C, Pfaller CK, Conzelmann K (2021): Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization.
PLoS Pathog 17: e1009064.
Online-Abstract

Henss L, Auste A, Schürmann C, Schmidt C, von Rhein C, Mühlebach MD, Schnierle BS (2021): The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection.
J Gen Virol 102: 001574.
Text

Herrmann M, Yampolsky LY (2021): False and true positives in arthropod thermal adaptation candidate gene lists.
Genetica 149: 143-153.
Online-Abstract

Hethey C, Hartung N, Wangorsch G, Weisser K, Huisinga W (2021): Physiology-based toxicokinetic modelling of aluminium in rat and man.
Arch Toxicol 95: 2977-3000.
Online-Abstract

Hörner M, Jerez-Longres C, Hudek A, Hook S, Yousefi OS, Schamel WWA, Hörner C, Zurbriggen MD, Ye H, Wagner HJ, Weber W (2021): Spatiotemporally confined red light-controlled gene delivery at single-cell resolution using adeno-associated viral vectors.
Sci Adv 7: eabf0797.
Text

Irving M, Lanitis E, Migliorini D, Ivics Z, Guedan S (2021): Choosing the Right Tool for Genetic Engineering: Clinical Lessons from Chimeric Antigen Receptor-T Cells.
Hum Gene Ther 32: 1044-1058.
Text

Ivics Z (2021): Potent CAR-T Cells Engineered With Sleeping Beauty Transposon Vectors Display a Central Memory Phenotype.
Gene Ther 28: 3-5.
Online-Abstract

Jacob T, Wangorsch A, Vogel L, Reuter A, Mahler V, Wöhrl BM (2021): A Novel Isoallergen Dau c 1.0401 in Carrot: Stability, Allergenicity, and Comparison with Other Isoallergens.
Mol Nutr Food Res 65: e2001110.
Online-Abstract

Janssen MP, Nuebling CM, Lery FX, Maryuningsih YS, Epstein JS (2021): A WHO tool for risk-based decision making on blood safety interventions.
Transfusion 61: 503-515.
Text

Jeong KY, Lee J, Yuk JE, Park JH, Ferreira F, Sang MK, Lee YS, Vogel L, Park KH, Park JW (2021): Characterization of the major allergen, Que ac 1, from sawtooth oak pollen.
Allergy 76: 2626-2629.
Online-Abstract

Jepsen K, Falk W, Brune F, Fimmers R, Jepsen S, Bekeredjian-Ding I (2021): Prevalence and antibiotic susceptibility trends of periodontal pathogens in the subgingival microbiota of German periodontitis patients: A retrospective surveillance study.
J Clin Periodontal 48: 1216-1227.
Online-Abstract

Johnen S, Harmening N, Marie C, Scherman D, Izsvák Z, Ivics Z, Walter P, Thumann G (2021): Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells using the Sleeping Beauty Transposon System.
J Vis Exp: e61987.
Online-Abstract

Kaiser LM, Harms M, Sauter D, Rawat VPS, Glitscher M, Hildt E, Tews D, Hunter Z, Münch J, Buske C (2021): Targeting of CXCR4 by the Naturally Occurring CXCR4 Antagonist EPI-X4 in Waldenström’s Macroglobulinemia.
Cancers (Basel) 13: 826.
Text

Kamp C, Becker B, Matheis W, Öppling V, Bekeredjian-Ding I (2021): How to draw the line - Raman spectroscopy as a tool for the assessment of biomedicines.
Biol Chem 402: 1001-1006.
Online-Abstract

Keipert C, Drechsel-Bäuerle U, Oberle D, Müller-Olling M, Hilger A (2021): Epidemiological Challenges in Rare Bleeding Disorders: FVIII Inhibitor Incidence in Haemophilia A Patients - A Known Issue of Unknown Origin.
Int J Environ Res Public Health 18: 225.
Online-Abstract

Klimka A, Mertins S, Nicolai AK, Rummler LM, Higgins PG, Günther SD, Tosetti B, Krut O, Krönke M (2021): Epitope-specific immunity against Staphylococcus aureus coproporphyrinogen III oxidase.
NPJ Vaccines 6: 11.
Text

König R, Münk C (2021): Special Issue: 'Innate Immune Sensing of Viruses and Viral Evasion'.
Viruses 13: 567.
Text

Konkle BA, Recht M, Hilger A, Marks P (2021): The critical need for postmarketing surveillance in gene therapy for haemophilia.
Haemophilia 27: 126-131.
Text

Krause M, Crauwels P, Blanco Pérez F, Globisch M, Wangorsch A, Henle T, Lidholm J, van Zandbergen G, Vieths S, Scheurer S, Toda M (2021): Human monocyte-derived type 1 and 2 macrophages recognize Ara h 1, a major peanut allergen, by different mechanisms.
Sci Rep 11: 10141.
Text

Kurki P, Barry S, Bourges I, Tsantili P, Wolff-Holz E (2021): Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective.
Drugs 81: 1881-1896.
Online-Abstract

Lapaillerie D, Lelandais B, Mauro E, Lagadec F, Tumiotto C, Miskey C, Ferran G, Kuschner N, Calmels C, Métifiot M, Rooryck C, Ivics Z, Ruff M, Zimmer C, Lesbats P, Toutain J, Parissi V (2021): Modulation of the intrinsic chromatin binding property of HIV-1 integrase by LEDGF/p75.
Nucleic Acids Res 49: 11241-11256.
Text

Lasch F, Guizzaro L, Aguirre Dávila L, Müller-Vahl K, Koch A (2021): Potential impact of COVID-19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA-TICS study.
Pharm Stat 20: 675-691.
Online-Abstract

Lin YJ, Flaczyk A, Wolfheimer S, Goretzki A, Jamin A, Wangorsch A, Vieths S, Scheurer S, Schülke S (2021): The Fusion Protein rFlaA:Betv1 Modulates DC Responses by a p38-MAPK and COX2-Dependent Secretion of PGE2 from Epithelial Cells.
Cells 10: 3415.
Online-Abstract

Lin YJ, Papp G, Miskey C, Fiedler A, Goretzki S, Wolfheimer S, Crauwels P, Ivics Z, van Zandbergen G, Vieths S, Scheurer S, Schülke S (2021): The flagellin:allergen fusion protein rFlaA:Betv1 induces a MyD88- and MAPK-dependent activation of glucose metabolism in macrophages.
Cells 10: 2614.
Online-Abstract

Lyons SA, Datema MR, Le TTM, Asero R, Barreales L, Belohlavkova S, de Blay F, Clausen M, Dubakiene R, Fernández-Perez C, Fritsche P, Gislason D, Hoffmann-Sommergruber K, Jedrzejczak-Czechowicz M, Longejan L, Kowalski ML, Kralimarkova T, Lidholm J, Papdopoulos NG, Bontoppidan B, Popov TA, Del Prado N, Purohit A, Reig I, Seneviratne SL, Sinaniotis A, Vassilopoulou E, Versteeg SA, Vieths S, Zwinderman AH, Welsing PMJ, Mills ENC, Ballmer-Weber B, Knulst AC, Fernández-Rivas M, Van Ree R (2021): Walnut Allergy across Europe: Distribution of Allergen Sensitization Patterns and Prediction of Severity.
J Allergy Clin Immunol Pract 9: 225-235.e10.
Online-Abstract

Mahler V (2021): Neue Allergene für die Berufsdermatologie?.
Hautarzt 72: 474-483.
Online-Abstract

Mahler V, Uter W (2021): Epicutaneous Patch Testing in Type IV Allergy Diagnostics: State of the Art and Best Practice Recommendations.
Handb Exp Pharmacol 268: 405-433.
Online-Abstract

Meyer H (2021): COVID-19-Impfstoffe – Übersicht über in Europa zugelassene oder im Zulassungsprozess befindliche Impfstofftypen.
Bulletin zur Arzneimittelsicherheit 12: 20-22.
Text

Michels A, Frank AM, Günther DM, Mataei M, Börner K, Grimm D, Hartmann J, Buchholz CJ (2021): Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8.
Mol Ther Methods Clin Dev 23: 334-347.
Online-Abstract

Miskei M, Horváth A, Viola L, Varga L, Nagy E, Feró O, Karányi Z, Roszik J, Miskey C, Ivics Z, Székvölgyi L (2021): Genome-wide mapping of binding sites of the transposase-derived SETMAR protein in the human genome.
Comput Struct Biotechnol J 19: 4032-4041.
Online-Abstract

Müller S, Buchholz CJ, Funk M, Keller-Stanislawski B (2021): Überprüfung des Leukämierisikos bei der Behandlung der Beta-Thalassämie mit dem Gentherapeutikum Zynteglo® – europäisches Risikoverfahren (Referral Procedure, Article 20 of Regulation (EC) No 726/2004).
Bulletin zur Arzneimittelsicherheit 12: 4-9.
Text

Müller-Olling M, Vahlensieck U, Hilger A (2021): Heterogeneity in COVID-19 Convalescent Plasma Clinical Trials.
Clin Pharmacol Ther 111: 995-1000.
Text

Musuamba FT, Skottheim Rusten I, Lesage R, Russo G, Bursi R, Emili L, Wangorsch G, Manolis E, Karlsson KE, Kulesza A, Courcelles E, Boissel JP, Rousseau CF, Voisin EM, Alessandrello R, Curado N, Dall'ara E, Rodriguez B, Pappalardo F, Geris L (2021): Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility.
CPT Pharmacometrics Syst Pharmacol 10: 804-825.
Text

Nettelbeck DM, Leber MF, Altomonte J, Angelova A, Beil J, Berchtold S, Delic M, Eberle J, Ehrhardt A, Engeland CE, Fechner H, Geletneky K, Goepfert K, Holm PS, Kochanek S, Kreppel F, Krutzke L, Kühnel F, Lang KS, Marchini A, Moehler M, Mühlebach MD, Naumann U, Nawroth R, Nüesch J, Rommelaere J, Lauer UM, Ungerechts G (2021): Virotherapy in Germany - Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies.
Viruses 13: 1420.
Text

Nguyen MTH, Krause G, Keller-Stanislawski B, Glöckner S, Mentzer D, Ott JJ (2021): Postmarketing Safety Monitoring After Influenza Vaccination Using a Mobile Health App: Prospective Longitudinal Feasibility Study.
JMIR Mhealth Uhealth 9: e26289.
Text

Niles MA, Gogesch P, Kronhart S, Ortega Iannazzo S, Kochs G, Waibler Z, Anzaghe M (2021): Macrophages and dendritic cells are not the major source of pro-inflammatory cytokines upon SARS-CoV-2 infection.
Front Immunol 12: 647824.
Online-Abstract

Njeru SN, Muema JM (2021): In vitro cytotoxicity of Aspilia pluriseta Schweinf. extract fractions.
BMC Res Notes 14: 57.
Text

Ochmann MT, Ivics Z (2021): Jumping Ahead with Sleeping Beauty: Mechanistic Insights into Cut-and-Paste Transposition.
Viruses 13: 76.
Text

Orru' S, Poetzsch K, Hoffelner M, Heiden M, Funk MB, Keller-Stanislawski B, Oberle D (2021): Unerwünschte Reaktionen bei der Blutspende: Ergebnisse einer Online-Umfrage unter Spenderinnen und Spendern in Deutschland.
Bulletin zur Arzneimittelsicherheit 12: 18-24.
Text

Orru' S, Poetzsch K, Hoffelner M, Heiden M, Funk MB, Keller-Stanislawski B, Oberle D (2021): Blood Donation-Related Adverse Reactions: Results of an Online Survey among Donors in Germany (2018).
Transfus Med Hemother 48: 272-283.
Text

Paulus K, Gaunitz F, Floßdorf S, Reuter A, Jamin A, Holzhauser T, Mahler V (2021): Post-mortem Allergiediagnostik bei Verdacht auf anaphylaktische Schockreaktion auf "Nüsse".
Allergologie 44: 427-431.

Petry M, Palus M, Leitzen E, Mitterreiter JG, Huang B, Kröger A, Verjans GMGM, Baumgärtner W, Rimmelzwaan GF, Ruzek D, Osterhaus A, Prajeeth CK (2021): Immunity to TBEV Related Flaviviruses with Reduced Pathogenicity Protects Mice from Disease but Not from TBEV Entry into the CNS.
Vaccines (Basel) 9: 196.
Online-Abstract

Pfaar O, Bergmann KC, Bonini S, Compalati E, Domis N, de Blay F, de Kam PJ, Devillier P, Durham SR, Ellis AK, Gherasim A, Haya L, Hohlfeld JM, Horak F, Iinuma T, Jacobs RL, Jacobi HH, Jutel M, Kaul S, Kelly S, Klimek L, Larché M, Lemell P, Mahler V, Nolte H, Okamoto Y, Patel P, Rabin RL, Rather C, Sager A, Salapatek A, Sigsgaard T, Togias A, Willers C, Yang J, Zieglmayer R, Zuberbier T, Zieglmayer P (2021): Technical standards in allergen exposure chambers worldwide - an EAACI Task Force Report.
Allergy 76: 3589-3612.
Text

Pfaar O, Creticos PS, Kleine-Tebbe J, Canonica GW, Palomares O, Schülke S (2021): One Hundred Ten Years of Allergen Immunotherapy: A Broad Look Into the Future.
J Allergy Clin Immunol Pract 9: 1791-1803.
Online-Abstract

Pfaar O, Mahler V (2021): Allergic reactions to COVID-19 -vaccinations - unveiling the secret(s).
Allergy 76: 1621-1623.
Online-Abstract

Pfaller CK, George CX, Samuel CE (2021): Adenosine Deaminases Acting on RNA (ADARs) and Viral Infections.
Annu Rev Virol 8: 239-264.
Online-Abstract

Pinheiro LC, Giezen TJ, Wolff-Holz E, Weise M, Laslop A, Hidalgo-Simon A (2021): Identifiability of biologicals: an analysis using the EMA adverse drug reaction database.
Clin Pharmacol Ther 110: 1311-1317.
Online-Abstract

Plesker R, Hintereder G (2021): Spontaneous (Hashimoto-like) chronic lymphocytic thyroiditis in a rhesus macaque (Macaca mulatta).
Primate Biol 8: 37-42.
Text

Pott F, Postmus D, Brown RJP, Wyler E, Neumann E, Landthaler M, Goffinet C (2021): Single-cell analysis of arthritogenic alphavirus-infected human synovial fibroblasts links low abundance of viral RNA to induction of innate immunity and arthralgia-associated gene expression.
Emerg Microbes Infect 10: 2151-2168.
Text

Prax M, Spindler-Raffel E, McDonald CP, Bearne J, Satake M, Kozakai M, Rojo J, Hanschmann KO, Lambrecht B, Grundmann U, O'Flaherty N, Klimek A, Bekeredjian-Ding I, Gathof BS, Störmer M, Süßner S, Renke C, Lee CK, Knabbe C, Volllmer T, Keil SD, Shipps ME, Wagner SJ, Jentsch U, Mpumlwana X, Cloutier M, Bringmann P, Lu T, Ramirez-Arcos S, Kou Y, Krut O, ISBT Transfusion-Transmitted Infectious Diseases Working Party, Subgroup on Bacteria (2021): Establishment of Transfusion-Relevant Bacteria Reference Strains for Red Blood Cells.
Vox Sang 116: 692-701.
Text

Prommersberger S, Reiser M, Beckmann J, Danhof S, Amberger M, Quade-Lyssy P, Hermann Einsele H, Hudecek M, Bonig H, Ivics Z (2021): CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma.
Gene Ther 28: 560-571.
Online-Abstract

Puyskens A, Krause E, Michel J, Nübling CM, Scheiblauer H, Bourquain D, Grossegesse M, Valusenko R, Corman VM, Drosten C, Zwirglmaier K, Wölfel R, Lange C, Kramer J, Friesen J, Ignatius R, Müller M, Schmidt-Chanasit J, Emmerich P, Schaade L, Nitsche A (2021): Establishment of a specimen panel for the decentralised technical evaluation of the sensitivity of 31 rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021.
Euro Surveill 26: 2100442.
Online-Abstract

Qu B, Brown RJP (2021): Strategies to Inhibit Hepatitis B Virus at the Transcript Level.
Viruses 13: 1327.
Online-Abstract

Reimann M, Schrezenmeier JF, Richter-Pechanska P, Dolnik A, Hick TP, Schleich K, Cai X, Fan DNY, Lohneis P, Masswig S, Denker S, Busse A, Knittel G, Flümann R, Childs D, Childs L, Gätjens-Sanchez AM, Bullinger L, Rosenwald A, Reinhardt HC, Schmitt CA (2021): Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas.
Blood 137: 2785-2799.
Online-Abstract

Reindl LM, Albinger N, Bexte T, Müller S, Hartmann J, Ullrich E (2021): Immunotherapy with NK cells: recent developments in gene modification open up new avenues.
Oncoimmunology 9: 1777651.
Text

Richter E, Al Arashi D, Schulte B, Bode C, Marx B, Aldabbagh S, Schlüter C, Kümmerer BM, Oldenburg J, Funk MB, Putensen C, Schmithausen RM, Hartmann G, Eis-Hübinger A, Streeck H (2021): Detectable SARS-CoV-2 RNAemia in Critically Ill Patients, but Not in Mild and Asymptomatic Infections.
Transfus Med Hemother 48: 154-159.
Text

Rossmann L, Bagola K, Stephen T, Gerards AL, Walber B, Ullrich A, Schülke S, Kamp C, Spreitzer I, Hasan M, David-Watine B, Shorte S, Bastian M, van Zandbergen G (2021): Distinct single-component adjuvants steer human DC-mediated T-cell polarization via Toll-like receptor signaling toward a potent antiviral immune response.
Proc Natl Acad Sci U S A 118: e2103651118.
Online-Abstract

Sabino C, Bender D, Herrlein ML, Hildt E (2021): The epidermal growth factor receptor is a relevant host factor in the early stages of Zika virus life cycle in vitro.
J Virol 95: e0119521.
Online-Abstract

Sampath V, Rabinowitz G, Shah M, Jain S, Diamant Z, Jesenak M, Rabin R, Jesenak M, Vieths S, Agache I, Akdis M, Barber D, Breiteneder H, Chinthrajah S, Chivato T, Collins W, Eiwegger T, Fast K, Fokkens W, O'Hehir RE, Ollert M, O'Mahony L, Palomares O, Pfaar O, Riggioni C, Shamji MH, Sokolowska M, Jose Torres M, Traidl-Hoffmann C, van Zelm M, Wang Y, Zhang L (2021): Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives.
Allergy 76: 1640-1660.
Text

Samukange WT, Kluempers V, Porwal M, Mudyiwenyama L, Mutoti K, Aineplan N, Gardarsdottir H, Mantel-Teeuwisse AK, Nuebling CM (2021): Implementation and performance of haemovigilance systems in 10 sub-saharan African countries is sub-optimal.
BMC Health Serv Res 21: 1258.
Online-Abstract

Sandoval-Villegas N, Nurieva W, Amberger M, Ivics Z (2021): Contemporary Transposon Tools: A Review and Guide through Mechanisms and Applications of Sleeping Beauty, piggyBac and Tol2 for Genome Engineering.
Int J Mol Sci 22: 5084.
Text

Scheiblauer H, Filomena A, Nitsche A, Puyskens A, Corman VM, Drosten C, Zwirglmaier K, Lange C, Emmerich P, Müller M, Knauer O, Nübling CM (2021): Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021.
Euro Surveill 26: 2100441.
Text

Scheurer S, van Ree R, Vieths S (2021): The Role of Lipid Transfer Proteins as Food and Pollen Allergens Outside the Mediterranean Area.
Curr Allergy Asthma Rep 21: 7.
Online-Abstract

Schmidt C, Perkovic M, Schnierle BS (2021): Development of a Sensitive Detection Method for Alphaviruses and Its Use as a Virus Neutralization Assay.
Viruses 13: 1191.
Text

Schnierle BS (2021): Reply to Ringlander et al..
J Infect Dis 223: 1833.

Schöbel A, Nguyen-Dinh V, Schumann GG, Herker E (2021): Hepatitis C virus infection restricts human LINE-1 retrotransposition in hepatoma cells.
PLoS Pathog 17: e1009496.
Text

Schwarzer A, Talbot SR, Selich A, Morgan M, Schott JW, Dittrich-Breiholz O, Bastone AL, Weigel B, Ha TC, Dziadek V, Gijsbers R, Thrasher AJ, Staal FJ, Gaspar HB, Modlich U, Schambach A, Rothe M (2021): Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learning.
Mol Ther 29: 3383-3397.
Online-Abstract

Seitz R, Gürtler L, Schramm W (2021): COVID-19 Convalescent Plasma: No Definite Answer Yet.
J Blood Lymph 11: 265.
Text

Sekyere SO, Port K, Deterding K, Cornberg M, Wedemeyer H (2021): Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients.
United European Gastroenterol J 9: 486-496.
Online-Abstract

Shen D, Song C, Miskey C, Chan S, Guan Z, Sang Y, Wang Y, Chen C, Wang X, Müller F, Ivics Z, Gao B (2021): A native, highly active Tc1/mariner transposon from zebrafish (ZB) offers an efficient genetic manipulation tool for vertebrates.
Nucleic Acids Res 49: 2126-2140.
Text

Siering O, Sawatsky B, Pfaller CK (2021): C Protein is Essential for Canine Distemper Virus Virulence and Pathogenicity in Ferrets.
J Virol 95: e01840-20.
Online-Abstract

Sokolowska M, Eiwegger T, Ollert M, Torres MJ, Barber D, Del Giacco S, Jutel M, Nadeau KC, Palomares O, Rabin RL, Riggioni C, Vieths S, Agache T, Shamji MH (2021): EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines.
Allergy 76: 1629-1639.
Online-Abstract

Srivastav S, Dankov A, Adanalic M, Grzeschik R, Tran V, Pagel-Wieder S, Gessler F, Spreitzer I, Scholz T, Schnierle B, Anastasiou OE, Dittmer U, Schlücker S (2021): Rapid and Sensitive SERS-Based Lateral Flow Test for SARS-CoV2-Specific IgM/IgG Antibodies.
Anal Chem 93: 12391-12399.
Online-Abstract

Starokozhko V, Kallio M, Kumlin Howell A, Makinen Salmi A, Andrew-Nielsen G, Goldammer M, Burggraf M, Löbker W, Böhmer A, Agricola E, de Vries CS, Pasmooij AMG, Mol PGM, STARS consortium (2021): Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap.
Drug Discov Today 26: 283-288.
Text

Stelzl E, Ciesek S, Cornberg M, Maasoumy B, Heim A, Chudy M, Olivero A, Miklau FN, Nickel A, Reinhardt A, Dietzsch M, Kessler HH (2021): Reliable quantification of plasma HDV RNA is of paramount importance for treatment monitoring: A European multicenter study.
J Clin Virol 142: 104932.
Online-Abstract

Taconet L, Seifner A, Baylis SA, Chudy M, Kreß J, Mathys E, Wirz M, Buchheit KH, Behr-Gross ME (2021): Detection of hepatitis C virus and parvovirus B19 in human plasma pools by nucleic-acid amplification techniques - Trends in results of EDQM proficiency testing studies from 2004 to 2018.
Biologicals 71: 9-19.
Online-Abstract

Tegtmeyer B, Vieyres G, Todt D, Lauber C, Ginkel C, Engelmann M, Herrmann M, Pfaller CK, Vondran FWR, Broering R, Vafadarnejad E, Saliba AE, Puff C, Baumgärtner W, Miskey C, Ivics Z, Steinmann E, Pietschmann T, Brown RJP (2021): Initial HCV infection of adult hepatocytes triggers a temporally structured transcriptional program containing diverse pro- and anti-viral elements.
J Virology 95: e00245-21.
Online-Abstract

Theuerkauf SA, Michels A, Riechert V, Maier TJ, Flory E, Cichutek K, Buchholz CJ (2021): Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without.
iScience 24: 102170.
Online-Abstract

Tichá O, Klemm D, Moos L, Bekeredjian-Ding I (2021): A cell-based in vitro assay for testing of immunological integrity of Tetanus toxoid vaccine antigen.
NPJ Vaccines 6: 88.
Text

Ticha O, Moos L, Bekeredjian-Ding I (2021): Effects of long-term cryopreservation of PBMC on recovery of B cell subpopulations.
J Immunol Methods 495: 113081.
Text

Ticha O, Slanina P, Moos L, Stichova J, Vlkova M, Bekeredjian-Ding I (2021): TNFR2 expression is a hallmark of human memory B cells with suppressive function.
Eur J Immunol 51.
Text

Tosetti B, Ward B, Grumme D, Herb M, Schramm M, Utermöhlen O, Heukamp LC, Krönke M, Krut O (2021): NOX2 Deficiency Permits Sustained Survival of S. aureus in Macrophages and Contributes to Severity of Infection.
Front Immunol 12: 633629.
Text

Trullas A, Delgado J, Genazzani A, Müller-Berghaus J, Migali C, Müller-Egert S, Zander H, Enzmann H, Pignatti F (2021): The EMA assessment of pembrolizumab as monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer.
ESMO Open 6: 100145.
Text

van Heuvel Y, Berg K, Hirch T, Winn K, Modlich U, Stitz J (2021): Establishment of a novel stable human suspension packaging cell line producing ecotropic retroviral MLV(PVC-211) vectors efficiently transducing murine hematopoietic stem and progenitor cells.
J Virol Methods 297: 114243.
Online-Abstract

Vandeputte J, Saville M, Cavaleri M, Friede M, Hacker A, Mueller SO, Rizzi R, Smith D, Thirstrup S, Wagner R, Baay M, Neels P (2021): IABS/CEPI platform technology webinar: Is it possible to reduce the vaccine development time?.
Biologicals 71: 55-60.
Text

Veinalde R, Pidelaserra-Martí G, Moulin C, Jeworoski LM, Küther L, Buchholz CJ, Jäger D, Ungerechts G, Engeland CE (2021): Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory.
Mol Ther Oncolytics 24: 43-58.
Text

von Rhein C, Scholz T, Henss L, Kronstein-Wiedemann R, Schwarz T, Rodionov RN, Corman VM, Tonn T, Schnierle BS (2021): Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma.
J Virol Methods 288: 114031.
Text

Wagner R, Hildt E, Grabski E, Sun Y, Meyer H, Lommel A, Keller-Stanislawski B, Müller-Berghaus J, Cichutek K (2021): Accelerated Development of COVID-19 Vaccines: Technology Platforms, Benefits, and Associated Risks.
Vaccines (Basel) 9: 747.
Text

Wangorsch A, Jamin A, Eichhorn S, Pablos I, Sharma S, Schweidler B, Kastner B, Wildner S, Saloga J, Führer F, Reyna Orozco RR, Sherkat R, Sadeghi S, Teifoori F, Park JW, Briza P, Vieths S, Ferreira F, Arora N, Lidholm J, Gadermaier G, Scheurer S (2021): Component-Resolved Diagnosis of American Cockroach (Periplaneta americana) Allergy in Patients From Different Geographical Areas.
Front Allergy 2: 691627.
Text

Wedi B, Aberer W, Brockow K, Dickel H, Brehler R, Jakob T, Kreft B, Mahler V, Merk HF, Mülleneisen N, Ott H, Pfützner W, Röseler S, Ruëff F, Sunderkötter C, Trautmann A, Treudler R, Worm M, Wurpts G (2021): Penicillin-Toleranzinduktion in der Schwangerschaft: Allergologische Stellungnahme zur Empfehlung der aktuellen Leitlinie Diagnostik und Therapie der Syphilis (AWMF-Register-Nr. 059-002).
Hautarzt 72: 349-353.
Online-Abstract

Weidner T, Agarwal S, Perian S, Fusil F, Braun G, Hartmann J, Verhoeyen E, Buchholz CJ (2021): Genetic in vivo engineering of human T lymphocytes in mouse models.
Nat Protoc 16: 3210-3240.
Text

Weisser K, Kling K, Huth C, Keller-Stanislawski B, Mahler V (2021): Was ist bei positiver Allergieanamnese vor einer Impfung gegen COVID-19 zu beachten?.
Bulletin zur Arzneimittelsicherheit 12: 23-26.
Text

Wenk BM, Mbunkah HA, Nsanwe NN, Mbu ET, Besong LM, Sama BA, Orock E, Leemann C, Mentzer KJ (2021): Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon.
J Antimicrob Chemother 76: 124-129.
Online-Abstract

Wenzel A, Thomas J, Wolf R (2021): Pharmakovigilanzreport immunologische Tierarzneimittel: Analyse der Nebenwirkungsmeldungen in Deutschland aus dem Jahr 2020.
DTBl 69: 1044-1054.
Volltext

Whitehouse H, Uter W, Geier J, Ballmer-Weber B, Bauer A, Cooper S, Czarnecka-Operacz M, Dagmar S, Dickel H, Belloni Fortina A, Gallo R, Giménez-Arnau AM, Johnston GA, Laresse Filon F, Mahler V, Pesonen M, Rustemeyer T, Schuttelaar MLA, Valiukevičien S, Weisshaar E, Werfel T, Wilkinson SM (2021): Formaldehyde 2% is not a useful means of detecting allergy to formaldehyde releasers- results of the ESSCA network, 2015 - 2018.
Contact Dermatitis 84: 95-102.
Online-Abstract

Wittwer K, Anderson DE, Pfeffermann K, Cox RM, Wolf JD, Santibanez S, Mankertz A, Plesker R, Sticher ZM, Kolkykhalov AA, Natchus MG, Pfaller CK, Plemper RK, von Messling V (2021): Small-molecule polymerase inhibitor protects non-human primates from measles and reduces shedding.
Nat Commun 12: 5233.
Text

Wolff-Holz E (2021): Sicherheit, Immunogenität und Austauschbarkeit von Biosimilars – monoklonale Antikörper und Fusionsproteine mit Antikörperanteil im Fokus.
Bulletin zur Arzneimittelsicherheit 12: 19-24.
Text

Worm M, Reese I, Ballmer-Weber B, Beyer K, Bischoff SC, Bohle B, Brockow K, Claßen M, Fischer PJ, Hamelmann E, Jappe U, Kleine-Tebbe J, Klimek L, Koletzko B, Lange L, Lau S, Lepp U, Mahler V, Nemat K, Raithel M, Saloga J, Schäfer C, Schnadt S, Schreiber J, Szépfalusi Z, Treudler R, Wagenmann M, Werfel T, Zuberbier T (2021): Update of the S2k guideline on the management of IgE-mediated food allergies.
Allergol Select 5: 195-243.
Text

Zhu S, Stanslowsky N, Fernández-Trillo J, Mamo TM, Yu P, Kalmbach N, Ritter B, Eggenschwiler R, Ouwendijk WJD, Mzinza D, Tan L, Leffler A, Spohn M, Brown RJP, Kropp KA, Kaever V, Ha TC, Narayanan P, Grundhoff A, Förster R, Schambach A, Verjans GMGM, Schmidt M, Kispert A, Cantz T, Gomis A, Wegner F, Viejo-Borbolla A (2021): Generation of hiPSC-derived low threshold mechanoreceptors containing axonal termini resembling bulbous sensory nerve endings and expressing Piezo1 and Piezo2.
Stem Cell Res 56: 102535.
Online-Abstract

Zimmer J, Bridgewater J, Ferreira F, van Ree R, Rabin RL, Vieths S (2021): The History, Present and Future of Allergen Standardization in the United States and Europe.
Front Immunol 12: 725831.
Text

Zimmer J, Schmidt S, Kaul S, Costanzo A, Buchheit KH, Brown S, Carnés J, Chapman M, Chen A, De Neergaard M, Döring S, Hindley J, Holzhauser T, Jorajuria S, Le Tallec D, Lombardero M, Iacovacci P, Reese G, Sander I, Smith B, Strecker D, van Ree R, Zebina M, Vieths S (2021): Standardisation of allergen products: 4. Validation of a Candidate European Pharmacopoeia Standard Method for Quantification of Major Grass Pollen Allergen Allergen Phl p 5.
Allergy 77: 633-642.
Text

Zubeldia-Varela E, Barker-Tejeda TC, Blanco-Pérez F, Infante S, Zubeldia JM, Pérez-Gordo M (2021): Non-IgE-Mediated Gastrointestinal Food Protein-Induced Allergic Disorders. Clinical Perspectives and Analytical Approaches.
Foods 10: 2662.
Online-Abstract

Charitidis FT, Adabi E, Thalheimer FB, Clarke C, Buchholz CJ (2021): Monitoring CAR T cell generation with a CD8-targeted lentiviral vector by single-cell transcriptomics.
Mol Ther Methods Clin Dev 23: 359-369.
Online-Abstract

Demircan MB, Mgbecheta PC, Kresinsky A, Schnoeder TM, Schröder K, Heidel FH, Böhmer FD (2022): Combined Activity of the Redox-Modulating Compound Setanaxib (GKT137831) with Cytotoxic Agents in the Killing of Acute Myeloid Leukemia Cells.
Antioxidants (Basel) 11: 513.
Text

Demircan MB, Schnoeder TM, Mgbecheta PC, Schröder K, Böhmer FD, Heidel FH (2022): Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML).
J Cancer Res Clin Oncol 148: 1983–1990.
Text

Denk D, Petrocelli V, Conche C, Drachsler M, Ziegler PK, Braun A, Kress A, Nicolas AM, Mohs K, Becker C, Neurath MF, Farin HF, Buchholz CJ, Andreux PA, Rinsch C, Greten FR (2022): Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy.
Immunity 55: 2059-2073.
Text

Guerrouahen B, Elnaggar M, Al-Mohannadi A, Kizhakayil D, Bonini C, Benjamin R, Brentjens R, Buchholz CJ, Casorati G, Ferrone S, Locke FL, Martin F, Schambach A, Turtle C, Veys P, van der Vliet HJ, Maccalli C, EICCI Faculty Group (2021): Proceedings From the First International Workshop at Sidra Medicine: "Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development", 15 th-16 th February 2019, Doha, Qatar.
Front Immunol 11: 589381.
Text

Ho N, Agarwal S, Milani M, Cantore A, Buchholz CJ, Thalheimer FB (2022): In vivo generation of CAR T cells in the presence of human myeloid cells.
Mol Ther Methods Clin Dev 26: 144-156.
Text

Michels A, Frank AM, Günther DM, Mataei M, Börner K, Grimm D, Hartmann J, Buchholz CJ (2021): Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8.
Mol Ther Methods Clin Dev 23: 334-347.
Online-Abstract

Rahbar S, Shafiekhani S, Allahverdi A, Jamali A, Kheshtchin N, Ajami M, Mirsanei Z, Habibi S, Makkiabadi B, Hadjati J, Jafari AH (2022): Agent-based Modeling of Tumor and Immune System Interactions in Combinational Therapy with Low-dose 5-fluorouracil and Dendritic Cell Vaccine in Melanoma B16F10.
Iran J Allergy Asthma Immunol 21: 151-166.
Online-Abstract

Strecker MI, Wlotzka K, Strassheimer F, Roller B, Ludmirski G, König S, Röder J, Opitz C, Alekseeva T, Reul J, Sevenich L, Tonn T, Wels WS, Steinbach JP, Buchholz CJ, Burger MC (2022): AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma.
Oncoimmunology 11: e2127508.
Text

Theuerkauf SA, Michels A, Riechert V, Maier TJ, Flory E, Cichutek K, Buchholz CJ (2021): Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without.
iScience 24: 102170.
Online-Abstract

Veinalde R, Pidelaserra-Martí G, Moulin C, Jeworoski LM, Küther L, Buchholz CJ, Jäger D, Ungerechts G, Engeland CE (2021): Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory.
Mol Ther Oncolytics 24: 43-58.
Text

Weidner T, Agarwal S, Perian S, Fusil F, Braun G, Hartmann J, Verhoeyen E, Buchholz CJ (2021): Genetic in vivo engineering of human T lymphocytes in mouse models.
Nat Protoc 16: 3210-3240.
Text

Albrecht M (2021): Turning off the alarm - Targeting alarmins and other epithelial mediators of allergic inflammation with biologics.
Allergol Select 9: 82-88.
Text

Albrecht M, Halle O, Gaedcke S, Pallenberg ST, Camargo Neumann J, Witt M, Roediger J, Schumacher M, Jirmo AC, Warnecke G, Jonigk D, Braubach P, DeLuca D, Hansen G, Dittrich AM (2022): Interleukin-17A and interleukin-22 production by conventional and non-conventional lymphocytes in three different end-stage lung diseases.
Clin Transl Immunology 11: e1398.
Text

Albrecht M, Schaub B, Gilles S, Köhl J, Altrichter S, Voehringer D, Spillner E, Ehlers M, Jönsson F, Loser K, Mayer JU, Rösner LM, Möbs C, Heine G, Pfützner W (2022): Current research and unmet needs in allergy and immunology in Germany: report presented by the DGfI and DGAKI task force Allergy & Immunology.
Eur J Immunol 52: 851-855.
Text

Blanco-Pérez F, Gonzalez-Menendez I, Stassen M, Kato Y, Laiño J, Kirberg J, Krause M, Martella M, Shibata N, Quintanilla-Martinez L, Feyerabend TB, Rodewald HR, Galli SJ, Vieths S, Scheurer S, Toda M (2022): Mast cells partly contribute to allergic enteritis development: findings in two different mast cell-deficient mice.
Allergy 77: 1051-1054.
Online-Abstract

Blanco-Pérez F, Steigerwald H, Schülke S, Vieths S, Toda M, Scheurer S (2021): The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota.
Curr Allergy Asthma Rep 21: 43.
Text

Bueno-Díaz C, Martín-Pedraza L, Parrón J, Cuesta-Herranz J, Cabanillas B, Pastor-Vargas C, Batanero E, Villalba M (2021): Characterization of Relevant Biomarkers for the Diagnosis of Food Allergies: An Overview of the 2S Albumin Family.
Foods 10: 1235.
Text

Cheng TY, Lin YJ, Saburi W, Vieths S, Scheurer S, Schülke S, Toda M (2021): β-(1→4)-Mannobiose Acts as an Immunostimulatory Molecule in Murine Dendritic Cells by Binding the TLR4/MD-2 Complex.
Cells 10: 1774.
Text

De Marchi L, Mainente F, Leonardi M, Scheurer S, Wangorsch A, Mahler V, Pilolli R, Sorio D, Zoccatelli G (2021): Allergenicity assessment of the edible cricket Acheta domesticus in terms of thermal and gastrointestinal processing and IgE cross-reactivity with shrimp.
Food Chem 359: 129878.
Online-Abstract

De Marchi L, Wangorsch A, Zoccatelli G (2021): Allergens from Edible Insects: Cross-reactivity and Effects of Processing.
Curr Allergy Asthma Rep 21: 35.
Online-Abstract

Gonzalez-Klein Z, Cuevas-Zuviria B, Hernandez-Ramirez G, Wangorsch A, Pazos-Castro D, Romero-Sahagun A, Pacios LF, Tome-Amat J, Scheurer S, Diaz-Perales A, Garrido-Arandia M (2021): The key to the allergenicity of lipid transfer protein (LTP) ligands: A structural characterization.
Biochim Biophys Acta Mol Cell Biol Lipids 1866: 158928.
Online-Abstract

Goretzki A, Lin YJ, Schülke S (2021): Immune metabolism in allergies, does it matter? ‐ A review of immune metabolic basics and adaptations associated with the activation of innate immune cells in allergy.
Allergy 76: 3314-3331.
Online-Abstract

Goretzki A, Lin YJ, Zimmermann J, Rainer H, Junker AC, Wolfheimer S, Vieths S, Scheurer S, Schülke S (2022): Role of Glycolysis and Fatty Acid Synthesis in the Activation and T Cell-Modulating Potential of Dendritic Cells Stimulated with a TLR5-Ligand Allergen Fusion Protein.
Int J Mol Sci 23: 12695.
Text

Goretzki A, Zimmermann J, Lin YJ, Schülke S (2022): Immune Metabolism-An Opportunity to Better Understand Allergic Pathology and Improve Treatment of Allergic Diseases?.
Front Allergy 3: 825931.
Text

Jacob T, Wangorsch A, Vogel L, Reuter A, Mahler V, Wöhrl BM (2021): A Novel Isoallergen Dau c 1.0401 in Carrot: Stability, Allergenicity, and Comparison with Other Isoallergens.
Mol Nutr Food Res 65: e2001110.
Online-Abstract

Krause M, Crauwels P, Blanco Pérez F, Globisch M, Wangorsch A, Henle T, Lidholm J, van Zandbergen G, Vieths S, Scheurer S, Toda M (2021): Human monocyte-derived type 1 and 2 macrophages recognize Ara h 1, a major peanut allergen, by different mechanisms.
Sci Rep 11: 10141.
Text

Lin YJ, Flaczyk A, Wolfheimer S, Goretzki A, Jamin A, Wangorsch A, Vieths S, Scheurer S, Schülke S (2021): The Fusion Protein rFlaA:Betv1 Modulates DC Responses by a p38-MAPK and COX2-Dependent Secretion of PGE2 from Epithelial Cells.
Cells 10: 3415.
Online-Abstract

Lin YJ, Papp G, Miskey C, Fiedler A, Goretzki S, Wolfheimer S, Crauwels P, Ivics Z, van Zandbergen G, Vieths S, Scheurer S, Schülke S (2021): The flagellin:allergen fusion protein rFlaA:Betv1 induces a MyD88- and MAPK-dependent activation of glucose metabolism in macrophages.
Cells 10: 2614.
Online-Abstract

Pfaar O, Creticos PS, Kleine-Tebbe J, Canonica GW, Palomares O, Schülke S (2021): One Hundred Ten Years of Allergen Immunotherapy: A Broad Look Into the Future.
J Allergy Clin Immunol Pract 9: 1791-1803.
Online-Abstract

Rossmann L, Bagola K, Stephen T, Gerards AL, Walber B, Ullrich A, Schülke S, Kamp C, Spreitzer I, Hasan M, David-Watine B, Shorte S, Bastian M, van Zandbergen G (2021): Distinct single-component adjuvants steer human DC-mediated T-cell polarization via Toll-like receptor signaling toward a potent antiviral immune response.
Proc Natl Acad Sci U S A 118: e2103651118.
Online-Abstract

Scheurer S, van Ree R, Vieths S (2021): The Role of Lipid Transfer Proteins as Food and Pollen Allergens Outside the Mediterranean Area.
Curr Allergy Asthma Rep 21: 7.
Online-Abstract

Steigerwald H, Blanco-Perez F, Albrecht M, Bender C, Wangorsch A, Endreß HU, Bunzel M, Mayorga C, Torres MJ, Scheurer S, Vieths S (2022): Does the Food Ingredient Pectin Provide a Risk for Patients Allergic to Non-Specific Lipid-Transfer Proteins?.
Foods 11: 13.
Online-Abstract

Wangorsch A, Jamin A, Eichhorn S, Pablos I, Sharma S, Schweidler B, Kastner B, Wildner S, Saloga J, Führer F, Reyna Orozco RR, Sherkat R, Sadeghi S, Teifoori F, Park JW, Briza P, Vieths S, Ferreira F, Arora N, Lidholm J, Gadermaier G, Scheurer S (2021): Component-Resolved Diagnosis of American Cockroach (Periplaneta americana) Allergy in Patients From Different Geographical Areas.
Front Allergy 2: 691627.
Text

Wangorsch A, Lidholm J, Mattsson LA, Larsson H, Reuter A, Gubesch M, Gadermaier G, Bures P, Scheurer S, Ballmer-Weber B, Vieths S (2022): Identification of a defensin as novel allergen in celery root: Api g 7 as a missing link in the diagnosis of celery allergy?.
Allergy 77: 1294-1296.
Online-Abstract

Wangorsch A, Scheurer S, Blanca M, Blanca-Lopez N, Somoza ML, Martin-Pedraza L (2022): Allergenic Properties and Molecular Characteristics of PR-1 Proteins.
Front Allergy 3: 824717.
Text

Zimmer J, Schmidt S, Kaul S, Costanzo A, Buchheit KH, Brown S, Carnés J, Chapman M, Chen A, De Neergaard M, Döring S, Hindley J, Holzhauser T, Jorajuria S, Le Tallec D, Lombardero M, Iacovacci P, Reese G, Sander I, Smith B, Strecker D, van Ree R, Zebina M, Vieths S (2021): Standardisation of allergen products: 4. Validation of a Candidate European Pharmacopoeia Standard Method for Quantification of Major Grass Pollen Allergen Allergen Phl p 5.
Allergy 77: 633-642.
Text

Zimmermann J, Goretzki A, Meier C, Wolfheimer S, Lin YJ, Rainer H, Krause M, Wedel S, Spies G, Führer F, Vieths S, Scheurer S, Schülke S (2022): Modulation of dendritic cell metabolism by an MPLA-adjuvanted allergen product for specific immunotherapy.
Front Immunol 13: 916491.
Text

Zubeldia-Varela E, Barker-Tejeda TC, Blanco-Pérez F, Infante S, Zubeldia JM, Pérez-Gordo M (2021): Non-IgE-Mediated Gastrointestinal Food Protein-Induced Allergic Disorders. Clinical Perspectives and Analytical Approaches.
Foods 10: 2662.
Online-Abstract

Aganovic K, Hertel C, Vogel RF, Johne R, Schlüter O, Schwarzenbolz U, Jäger H, Holzhauser T, Bergmair J, Roth A, Sevenich R, Bandick N, Kulling SE, Knorr D, Engel KH, Heinz V (2021): Aspects of high hydrostatic pressure food processing: Perspectives on technology and food safety.
Compr Rev Food Sci Food Saf 20: 3225-3266.
Online-Abstract

Bonertz A, Tripathi A, Zimmer J, Reeb C, Kaul S, Bridgewater J, Rabin RL, SI JE, Vieths S (2022): A regulator’s view on AIT clinical trials in the United States and Europe: Why successful studies fail to support licensure.
J Allergy Clin Immunol 149: 812-818.
Online-Abstract

Bousquet J, Agache I, Blain H, Jutel M, Ventura MT, Worm M, Del Giacco S, Benetos A, Bilo MB, Czarlewski W, Abdul Latiff AH, Al-Ahmad M, Angier E, Annesi-Maesano I, Atanaskovic-Markovic M, Bachert C, Barbaud A, Bedbrook A, Bennoor KS, Berghea EC, Bindslev-Jensen C, Bonini S, Bosnic-Anticevich S, Brockow K, Brussino L, Camargos P, Canonica GW, Cardona V, Carreiro-Martins P, Carriazo A, Casale T, Caubet JC, Cecchi L, Cherubini A, Christoff G, Chu DK, Cruz AA, Dokic D, El-Gamal Y, Ebisawa M, Eberlein B, Farrell J, Fernandez-Rivas M, Fokkens WJ , Fonseca JA, Gao Y, Gavazzi G, Gawlik R, Gelincik A , Gemicioğlu B, Gotua M, Guérin O, Haahtela T, Hoffmann-Sommergruber K, Hoffmann HJ, Hofmann M, Hrubisko M, lenaIllario M, Irani C, Ispayeva Z, Ivancevich JC, Julge K, Kaidashev I, Khaitov M, Knol E, Kraxner H, Kuna P, Kvedariene V, Lauerma A, Le LT, Le Moing V, Levin M, Louis R, Lourenco O, Mahler V, Martin FC, Matucci A, Milenkovic B, Miot S, Montella E, Morais-Almeida M, Mortz CG, Mullol J, Namazova-Baranova L, Neffen H, Nekam K, Niedoszytko M, Odemyr M, O'Hehir RE, Okamoto Y, Ollert M, Palomares O, Papadopoulos NG, Panzner P, Passalacqua G, Patella V, Petrovic M, Pfaar O, Pham-Thi N, Plavec D, Popov TA, Recto MT, Regateiro FS, Reynes J , Roller-Winsberger RE, Rolland Y, Romano A, Rondon C, Rottem M, Rouadi PW, Salles N, Samolinski B, Santos AF, Serpa FS, Sastre J, Schols JMGA, Scichilone N, Sediva A, Shamji MH, Sheikh A, Skypala I, Smolinska S, Sokolowska M, Sousa-Pinto B, Sova M, Stelmach R, Sturm G, Suppli Ulrik C, Todo-Bom AM, Toppila-Salmi S, Tsiligianni I, Torres M, Untersmayr E, Urrutia Pereira M, Valiulis A, Vitte J, Vultaggio A, Wallace D, Walusiak-Skorupa J, Wang DY , Waserman S, Yorgancioglu A, Yusuf OM, Zernotti M, Zidarn M, Chivato T, Akdis CA, Zuberbier T, Klimek L (2021): Management of anaphylaxis due to COVID-19 vaccines in the elderly.
Allergy 76: 2952-2964.
Online-Abstract

Chapman MD, Custovic A, Mills CEN, Holzhauser T: Molecular exposure: Systematic approaches, clinical significance, and harmonisation.
In: Hoffmann-Sommergruber K, Hilger C, Santos A, de las Vecillas L, Dramburg S / EAACI (Hrsg.), Molecular Allergology User’s Guide 2.0: John Wiley & Sons Ltd., 2022. S. 157-170, ISBN 978-3-9524815-4-7

Costa J, Bavaro SL, Benedé S, Diaz-Perales A, Bueno-Diaz C, Gelencser E, Klueber J, Larré C, Lozano-Ojalvo D, Lupi R, Mafra I, Mazzuchelli G, Molina E, Monaci L, Martin-Petraza L, Piras C, Rodrigues PM, Roncada P, Schrama D, Cirkovic-Velickovic T, Verhoeckx K, Villa C, Kuehn A, Hoffmann-Sommergruber K, Holzhauser T (2022): Are Physicochemical Properties Shaping the Allergenic Potency of Plant Allergens?.
Clin Rev Allergy Immunol 62: 37-63.
Online-Abstract

Costa J, Villa C, Verhoeckx K, Cirkovic-Velickovic T, Schrama D, Roncada P, Rodrigues PM, Piras C, Martín-Pedraza L, Monaci L, Molina E, Mazzucchelli G, Mafra I, Lupi R, Lozano-Ojalvo D, Larré C, Klueber J, Gelencser E, Bueno-Diaz C, Diaz-Perales A, Benedé S, Bavaro SL, Kuehn A, Hoffmann-Sommergruber K, Holzhauser T (2021): Are Physicochemical Properties Shaping the Allergenic Potency of Animal Allergens?.
Clin Rev Allergy Immunol 62: 1-36.
Online-Abstract

De Marchi L, Mainente F, Leonardi M, Scheurer S, Wangorsch A, Mahler V, Pilolli R, Sorio D, Zoccatelli G (2021): Allergenicity assessment of the edible cricket Acheta domesticus in terms of thermal and gastrointestinal processing and IgE cross-reactivity with shrimp.
Food Chem 359: 129878.
Online-Abstract

Dickel H, Bauer A, Brehler R, Mahler V, Merk HF, Neustädter I, Strömer K, Werfel T, Worm M, Geier J (2022): S1-Leitlinie Kontaktekzem.
J Dtsch Dermatol Ges 20: 711-734.
Text

Dickel H, Kuehn A, Dickel B, Bauer A, Becker D, Fartasch M, Haeberle M, John SM, Mahler V, Skudlik C, Weisshaar E, Werfel T, Geier J, Diepgen TL (2021): Assessment of the effects of a work-related allergy to seafood on the reduction of earning capacity in the context of BK No. 5101.
Allergol Select 5: 33-44.
Online-Abstract

Englert L, Mahler V, Bonertz A (2021): Regulatory Requirements for the Quality of Allergen Products for Allergen Immunotherapy of Food Allergy.
Curr Allergy Asthma Rep 21: 32.
Text

Forkel S, Cevik N, Schill T, Worm M, Mahler V, Weisshaar E, Vieluf D, Pfützner W, Löffler H, Schön MP, Geier J, Buhl T (2021): Atopische Hautdiathese ist stärker mit spezifischen Kontaktallergien assoziiert als atopische Dermatitis.
J Dtsch Dermatol Ges 19: 231-240.
Online-Abstract

Geier J, Ballmer-Weber B, Buhl T, Rieker-Schwienbacher J, Mahler V, Dickel H, Schubert S, IVDK (2022): Is benzyl alcohol a significant contact sensitizer?.
J Eur Acad Dermatol Venereol 36: 866-872.
Text

Gogesch P, Dudek S, van Zandbergen G, Waibler Z, Anzaghe M (2021): The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies.
Int J Mol Sci 22: 8947.
Text

Jacob T, Wangorsch A, Vogel L, Reuter A, Mahler V, Wöhrl BM (2021): A Novel Isoallergen Dau c 1.0401 in Carrot: Stability, Allergenicity, and Comparison with Other Isoallergens.
Mol Nutr Food Res 65: e2001110.
Online-Abstract

Jeong KY, Lee J, Yuk JE, Park JH, Ferreira F, Sang MK, Lee YS, Vogel L, Park KH, Park JW (2021): Characterization of the major allergen, Que ac 1, from sawtooth oak pollen.
Allergy 76: 2626-2629.
Online-Abstract

Jutel M, Torres MJ, Palomares O, Akdis CA, Eiwegger T, Untersmayr E, Barber D, Zemelka-Wiacek M, Kosowska A, Palmer E, Vieths S, Mahler V, Canonica GW, Nadeau K, Shamji MH, Agache I, EAACI Research and Outreach Committee Group (2022): COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals - EAACI recommendations.
Allergy 77: 2313-2336.
Text

Khaleva E, Rattu A, Brightling C, Bush A, Bossios A, Bourdin A, Chung KF, Chaudhuri R, Coleman C, Dahlén SE, Djukanovic R, Deschildre A, Fleming L, Fowler SJ, Gupta A, Hamelmann E, Hashimoto S, Hedlin G, Koppelman GH, Melén E, Murray CS, Pilette C, Porsbjerg C, Pike KC, Rusconi F, Williams C, Ahrens B, Alter P, Anckers F, van den Berge M, Blumchen K, Brusselle G, Clarke GW, Cunoosamy D, Dahlén B, Dixey P, Exley A, Frey U, Gaillard EA, Giovannini-Chami L, Grigg J, Hartenstein D, Heaney LG, Karadag B, Kaul S, Kull I, Licari A, Maitland-van der Zee AH, Mahler V, Schoos AM, Nagakumar P, Negus J, Nielsen H, Paton J, Pijnenburg M, Ramiconi V, Vilarnau SR, Principe S, Rutjes N, Saglani S, Seddon P, Singer F, Staudinger H, Turner S, Vijverberg S, Winders T, Yasinska V, Roberts G, COMSA working group in the 3TR consortium (2022): Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA).
Eur Respir J 61: 2200606.
Online-Abstract

Mahler V (2021): Neue Allergene für die Berufsdermatologie?.
Hautarzt 72: 474-483.
Online-Abstract

Mahler V, Junker AC (2022): Anaphylaxie auf Zusatzstoffe in Impfstoffen.
Allergo J 31: 22-39.
Text

Mahler V, Junker AC (2022): Anaphylaxis to additives in vaccines.
Allergo J Int 31: 123-136.
Text

Mahler V, Uter W (2021): Epicutaneous Patch Testing in Type IV Allergy Diagnostics: State of the Art and Best Practice Recommendations.
Handb Exp Pharmacol 268: 405-433.
Online-Abstract

Paulus K, Gaunitz F, Floßdorf S, Reuter A, Jamin A, Holzhauser T, Mahler V (2021): Post-mortem Allergiediagnostik bei Verdacht auf anaphylaktische Schockreaktion auf "Nüsse".
Allergologie 44: 427-431.

Pfaar O, Bergmann KC, Bonini S, Compalati E, Domis N, de Blay F, de Kam PJ, Devillier P, Durham SR, Ellis AK, Gherasim A, Haya L, Hohlfeld JM, Horak F, Iinuma T, Jacobs RL, Jacobi HH, Jutel M, Kaul S, Kelly S, Klimek L, Larché M, Lemell P, Mahler V, Nolte H, Okamoto Y, Patel P, Rabin RL, Rather C, Sager A, Salapatek A, Sigsgaard T, Togias A, Willers C, Yang J, Zieglmayer R, Zuberbier T, Zieglmayer P (2021): Technical standards in allergen exposure chambers worldwide - an EAACI Task Force Report.
Allergy 76: 3589-3612.
Text

Pfaar O, Mahler V (2021): Allergic reactions to COVID-19 -vaccinations - unveiling the secret(s).
Allergy 76: 1621-1623.
Online-Abstract

Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C (2022): Antibody response to SARS-CoV-2 for more than one year − kinetics and persistence of detection are predominantly determined by avidity progression and test design.
J Clin Virol 146: 105052.
Text

Wangorsch A, Jamin A, Eichhorn S, Pablos I, Sharma S, Schweidler B, Kastner B, Wildner S, Saloga J, Führer F, Reyna Orozco RR, Sherkat R, Sadeghi S, Teifoori F, Park JW, Briza P, Vieths S, Ferreira F, Arora N, Lidholm J, Gadermaier G, Scheurer S (2021): Component-Resolved Diagnosis of American Cockroach (Periplaneta americana) Allergy in Patients From Different Geographical Areas.
Front Allergy 2: 691627.
Text

Wangorsch A, Lidholm J, Mattsson LA, Larsson H, Reuter A, Gubesch M, Gadermaier G, Bures P, Scheurer S, Ballmer-Weber B, Vieths S (2022): Identification of a defensin as novel allergen in celery root: Api g 7 as a missing link in the diagnosis of celery allergy?.
Allergy 77: 1294-1296.
Online-Abstract

Wedi B, Aberer W, Brockow K, Dickel H, Brehler R, Jakob T, Kreft B, Mahler V, Merk HF, Mülleneisen N, Ott H, Pfützner W, Röseler S, Ruëff F, Sunderkötter C, Trautmann A, Treudler R, Worm M, Wurpts G (2021): Penicillin-Toleranzinduktion in der Schwangerschaft: Allergologische Stellungnahme zur Empfehlung der aktuellen Leitlinie Diagnostik und Therapie der Syphilis (AWMF-Register-Nr. 059-002).
Hautarzt 72: 349-353.
Online-Abstract

Weisser K, Kling K, Huth C, Keller-Stanislawski B, Mahler V (2021): Was ist bei positiver Allergieanamnese vor einer Impfung gegen COVID-19 zu beachten?.
Bulletin zur Arzneimittelsicherheit 12: 23-26.
Text

Whitehouse H, Uter W, Geier J, Ballmer-Weber B, Bauer A, Cooper S, Czarnecka-Operacz M, Dagmar S, Dickel H, Belloni Fortina A, Gallo R, Giménez-Arnau AM, Johnston GA, Laresse Filon F, Mahler V, Pesonen M, Rustemeyer T, Schuttelaar MLA, Valiukevičien S, Weisshaar E, Werfel T, Wilkinson SM (2021): Formaldehyde 2% is not a useful means of detecting allergy to formaldehyde releasers- results of the ESSCA network, 2015 - 2018.
Contact Dermatitis 84: 95-102.
Online-Abstract

Zahn T, Mhedhbi I, Hein S, Raupach J, Miskey C, Husria Y, Bayanga K, Bartel D, Vieths S, Ivics Z, Oberle D, Keller-Stanislawski K, Herrlein ML, Maier TJ, Hildt E (2022): Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19.
Allergy 77: 2053-2066.
Online-Abstract

Zimmer J, Bridgewater J, Ferreira F, van Ree R, Rabin RL, Vieths S (2021): The History, Present and Future of Allergen Standardization in the United States and Europe.
Front Immunol 12: 725831.
Text

Zimmer J, Schmidt S, Costanzo A, Buchheit KH, Brown S, Carnés J, Chapman M, Chen A, De Neergaard M, Döring S, Hindley J, Holzhauser T, Jorajuria S, Le Tallec D, Lombardero M, Iacovacci P, Reese G, Sander I, Smith B, Strecker D, van Ree R, Zebina M, Kaul S, Vieths S (2022): Validation of an ELISA method for quantification of the major Timothy grass pollen allergen Phl p 5a (BSP090).
Pharmeur Bio Sci Notes 2022: 55-86.
Online-Abstract

Zimmer J, Schmidt S, Kaul S, Costanzo A, Buchheit KH, Brown S, Carnés J, Chapman M, Chen A, De Neergaard M, Döring S, Hindley J, Holzhauser T, Jorajuria S, Le Tallec D, Lombardero M, Iacovacci P, Reese G, Sander I, Smith B, Strecker D, van Ree R, Zebina M, Vieths S (2021): Standardisation of allergen products: 4. Validation of a Candidate European Pharmacopoeia Standard Method for Quantification of Major Grass Pollen Allergen Allergen Phl p 5.
Allergy 77: 633-642.
Text

Zimmer J, Schmidt S, Klos J, Döring S, Strecker D, Vieths S, Kaul S (2022): The method makes the extract: Comparative analysis of birch pollen allergen extracts.
Clin Exp Allergy 52: 784-787.
Text

Zimmermann J, Goretzki A, Meier C, Wolfheimer S, Lin YJ, Rainer H, Krause M, Wedel S, Spies G, Führer F, Vieths S, Scheurer S, Schülke S (2022): Modulation of dendritic cell metabolism by an MPLA-adjuvanted allergen product for specific immunotherapy.
Front Immunol 13: 916491.
Text

Anliker B, Childs L, Rau J, Renner M, Schüle S, Schuessler-Lenz M, Sebe A (2022): Regulatory Considerations for Clinical Trial Applications with CRISPR-Based Medicinal Products.
CRISPR J 5: 364-376.
Online-Abstract

Ansah JK, Kafere C, Loua A, Nkansah E, Acquah ME, Mudyiwenyama L (2021): Regulation of blood services in Africa.
Transfus Clin Biol 28: 148-153.
Online-Abstract

Atemnkeng J, Heinrich J, Samukange WT, Kafere C, Mbunkah HA, Schoner C, Reinhardt J (2022): Report on the GHPP-BloodTrain online workshop on "Authorisation and Licensing of Blood Establishments - Review of quality documentation of blood and blood components", 5th-8th of July 2021.
Biologicals 80: 1-5.
Text

Baylis S, Nübling CM, Dimech W: Standardization of diagnostic assays.
In: Bamford DH, Zuckerman M (Hrsg.), Encyclopedia of Virology (Fourth Edition): Academic Press, 2021. S. 52-63, ISBN 978-0-12-814516-6

Baylis SA, Nübling CM (2022): Nucleic Acid Testing of Viral Pathogens: Traceability of the International Unit.
Clin Chem 68: 257-258.
Text

Baylis SA, Nübling CM (2021): Nucleic Acid Testing of Viral Pathogens: Traceability of the International Unit.
Clin Chem 68: 257-258.
Text

Correia Pinheiro L, Giezen TJ, Wolff-Holz E, Weise M, Laslop A, Hidalgo-Simon A (2021): Identifiability of Biologicals: An Analysis Using EudraVigilance, the European Union's Database of Reports of Suspected Adverse Drug Reactions.
Clin Pharmacol Ther 110: 1311-1317.
Text

Janssen MP, Nuebling CM, Lery FX, Maryuningsih YS, Epstein JS (2021): A WHO tool for risk-based decision making on blood safety interventions.
Transfusion 61: 503-515.
Text

Knezevic I, Mattiuzzo G, Page M, Nuebling CM, Griffiths E, Minor P (2022): Complexity of serological assays and misunderstandings of WHO International Units.
Clin Chem Lab Med 60: e223-e224.
Online-Abstract

Knezevic I, Mattiuzzo G, Page M, Minor P, Griffiths E, Nübling CM, Moorthy V (2022): WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific community.
Lancet Microbe 3: e235-e240.
Text

Kurki P, Barry S, Bourges I, Tsantili P, Wolff-Holz E (2021): Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective.
Drugs 81: 1881-1896.
Online-Abstract

Kurki P, Kang HN, Ekman N, Knezevic I, Weise M, Wolff-Holz E (2022): Regulatory Evaluation of Biosimilars: Refinement of Principles Based on the Scientific Evidence and Clinical Experience.
BioDrugs 36: 359-371.
Text

Liu M, Zhou T, Sheets R, Meyer H, Knezevic I (2022): WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20-22 April 2021.
Emerg Microbes Infect 11: 384-391.
Online-Abstract

Mbunkah H, Kafere C, Samukange W, Nübling CM, Reinhardt J (2022): Congress report: Online workshop on assessment of technical files for blood screening in vitro diagnostics for sub-Sahara African countries.
Transfus Med 32: 467-474.
Text

Meyer H (2021): COVID-19-Impfstoffe – Übersicht über in Europa zugelassene oder im Zulassungsprozess befindliche Impfstofftypen.
Bulletin zur Arzneimittelsicherheit 12: 20-22.
Text

Michaleas S, Moreno Oliver A, Mueller-Berghaus J, Sarac SB, van der Elst ME, Müller-Egert S, Zander H, Enzmann H, Pignatti F (2022): The European Medicines Agency review of sacituzumab govitecan for the treatment of triple-negative breast cancer.
ESMO Open 7: 100497.
Online-Abstract

Owusu Sekyere S, Škrnjug-Yudov I, Ateba Ngoa U, Juárez Hernández M, Abiri OT, Komeh JP, Janneh Kaira M, Marenah E, Kercula JD, Smith K, Rassokhina O, Meyer H, Conrad C (2022): Leveraging WHO's Global Benchmarking Tool to strengthen capacity in clinical trials oversight for public health emergencies: the GHPP VaccTrain model.
Global Health 18: 63.
Text

Owusu Sekyere S, Škrnjug-Yudov I, Pinz A, Meyer H, Conrad C (2022): The Pivotal Role of Quality Technical Structures for Clinical Trials Oversight in the Achievement of Long-Term Capacity Strengthening Outcomes.
Front Med (Lausanne) 9: 772605.
Text

Pinheiro LC, Giezen TJ, Wolff-Holz E, Weise M, Laslop A, Hidalgo-Simon A (2021): Identifiability of biologicals: an analysis using the EMA adverse drug reaction database.
Clin Pharmacol Ther 110: 1311-1317.
Online-Abstract

Puyskens A, Krause E, Michel J, Nübling CM, Scheiblauer H, Bourquain D, Grossegesse M, Valusenko R, Corman VM, Drosten C, Zwirglmaier K, Wölfel R, Lange C, Kramer J, Friesen J, Ignatius R, Müller M, Schmidt-Chanasit J, Emmerich P, Schaade L, Nitsche A (2021): Establishment of a specimen panel for the decentralised technical evaluation of the sensitivity of 31 rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021.
Euro Surveill 26: 2100442.
Online-Abstract

Samukange WT, Kluempers V, Porwal M, Mudyiwenyama L, Mutoti K, Aineplan N, Gardarsdottir H, Mantel-Teeuwisse AK, Nuebling CM (2021): Implementation and performance of haemovigilance systems in 10 sub-saharan African countries is sub-optimal.
BMC Health Serv Res 21: 1258.
Online-Abstract

Scheiblauer H, Filomena A, Nitsche A, Puyskens A, Corman VM, Drosten C, Zwirglmaier K, Lange C, Emmerich P, Müller M, Knauer O, Nübling CM (2021): Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021.
Euro Surveill 26: 2100441.
Text

Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C (2022): Antibody response to SARS-CoV-2 for more than one year − kinetics and persistence of detection are predominantly determined by avidity progression and test design.
J Clin Virol 146: 105052.
Text

Schüßler-Lenz M, Scherer J, Müller-Berghaus J (2022): Arzneimittel für neuartige Therapien (ATMP): Ankunft in der Versorgung.
Pharmakon 10: 337-343.
Text

Sekyere SO, Port K, Deterding K, Cornberg M, Wedemeyer H (2021): Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients.
United European Gastroenterol J 9: 486-496.
Online-Abstract

Starokozhko V, Kallio M, Kumlin Howell A, Makinen Salmi A, Andrew-Nielsen G, Goldammer M, Burggraf M, Löbker W, Böhmer A, Agricola E, de Vries CS, Pasmooij AMG, Mol PGM, STARS consortium (2021): Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap.
Drug Discov Today 26: 283-288.
Text

Trullas A, Delgado J, Genazzani A, Müller-Berghaus J, Migali C, Müller-Egert S, Zander H, Enzmann H, Pignatti F (2021): The EMA assessment of pembrolizumab as monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer.
ESMO Open 6: 100145.
Text

Wadhwa M, Kang HN, Thorpe R, Knezevic I, following participants of the WHO informal consultation on revision of guidelines on evaluation of similar biotherapeutic products, Aprea P, Bielsky MC, Ekman N, Heim HK, Joung J, Kurki P, Lacana E, Njue C, Nkansah E, Savkina M, Thorpe R, Yamaguchi T, Wadhwa M, Wang J, Weise M, Wolff-Holz E, other participants: Representatives of the Developing Countries Vaccine Manufacturers Network; Representatives of the Emerging Biopharmaceutical Manufacturers Network; Representatives of the IFPMA; Representatives of IGBA; Representative of the Latin American Association of Pharmaceutical Industries; Representative of the Singapore Association of Pharmaceutical Industries; WHO Secretariat (2022): WHO informal consultation on revision of guidelines on evaluation of similar biotherapeutic products, virtual meeting, 30 June - 2 July 2021.
Biologicals 76: 1-9.
Online-Abstract

Wagner R, Hildt E, Grabski E, Sun Y, Meyer H, Lommel A, Keller-Stanislawski B, Müller-Berghaus J, Cichutek K (2021): Accelerated Development of COVID-19 Vaccines: Technology Platforms, Benefits, and Associated Risks.
Vaccines (Basel) 9: 747.
Text

Wenk BM, Mbunkah HA, Nsanwe NN, Mbu ET, Besong LM, Sama BA, Orock E, Leemann C, Mentzer KJ (2021): Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon.
J Antimicrob Chemother 76: 124-129.
Online-Abstract

Wolff-Holz E (2021): Sicherheit, Immunogenität und Austauschbarkeit von Biosimilars – monoklonale Antikörper und Fusionsproteine mit Antikörperanteil im Fokus.
Bulletin zur Arzneimittelsicherheit 12: 19-24.
Text

Artunc F, Bohnert BN, Schneider JC, Staudner T, Sure F, Ilyaskin AV, Wörn M, Essigke D, Janessa A, Nielsen NV, Birkenfeld AL, Etscheid M, Haerteis S, Korbmacher C, Kanse SM (2022): Proteolytic activation of the epithelial sodium channel (ENaC) by factor VII activating protease (FSAP) and its relevance for sodium retention in nephrotic mice.
Pflugers Arch 474: 217-229.
Online-Abstract

Atemnkeng J, Heinrich J, Samukange WT, Kafere C, Mbunkah HA, Schoner C, Reinhardt J (2022): Report on the GHPP-BloodTrain online workshop on "Authorisation and Licensing of Blood Establishments - Review of quality documentation of blood and blood components", 5th-8th of July 2021.
Biologicals 80: 1-5.
Text

Berge-Seidl S, Nielsen NV, Rodriguez Alfonso AA, Etscheid M, Kandanur SPS, Haug BE, Stensland M, Thiede B, Karacan M, Preising N, Wiese S, Ständker L, Declerck PJ, Løset GÅ, Kanse SM (2022): Identification of a Phage Display-Derived Peptide Interacting with the N-Terminal Region of Factor VII Activating Protease (FSAP) Enables Characterization of Zymogen Activation.
ACS Chem Biol 17: 2631-2642.
Text

Eichler H, Feyer AK, Weitmann K, Hoffmann W, Henseler O, Opitz A, Patek A, Hans DN, Schönborn L, Greinacher A (2021): Population-Based Analysis of the Impact of Demographics on the Current and Future Blood Supply in the Saarland.
Transfus Med Hemother 48: 175-182.
Text

Etscheid M, Hanschmann KM, Sandset PM, Kanse SM (2022): Development of a Factor VII Activating Protease (FSAP) generation assay and its application in studying FSAP in venous thrombosis.
Thromb Res 220: 24-34.
Online-Abstract

Glitscher M, Himmelsbach K, Woytinek K, Schollmeier A, Johne R, Praefcke GJK, Hildt E (2021): Identification of the interferon-inducible GTPase GBP1 as major restriction factor for the Hepatitis E virus.
J Virol 95: e01564-20.
Online-Abstract

Gramstad OR, Kandanur SPS, Etscheid M, Nielsen EW, Kanse SM (2022): Factor VII activating protease (FSAP) is not essential in the pathophysiology of angioedema in patients with C1 inhibitor deficiency.
Mol Immunol 142: 95-104.
Online-Abstract

Keipert C, Drechsel-Bäuerle U, Oberle D, Müller-Olling M, Hilger A (2021): Epidemiological Challenges in Rare Bleeding Disorders: FVIII Inhibitor Incidence in Haemophilia A Patients - A Known Issue of Unknown Origin.
Int J Environ Res Public Health 18: 225.
Online-Abstract

Kim YJ, Manna D, Etscheid M, Leergaard TB, Kanse SM (2022): Factor VII activating protease (FSAP) inhibits the outcome of ischemic stroke in mouse models.
FASEB J 36: e22564.
Text

Konkle BA, Recht M, Hilger A, Marks P (2021): The critical need for postmarketing surveillance in gene therapy for haemophilia.
Haemophilia 27: 126-131.
Text

Mbunkah H, Kafere C, Samukange W, Nübling CM, Reinhardt J (2022): Congress report: Online workshop on assessment of technical files for blood screening in vitro diagnostics for sub-Sahara African countries.
Transfus Med 32: 467-474.
Text

Müller-Olling M, Vahlensieck U, Hilger A (2021): Heterogeneity in COVID-19 Convalescent Plasma Clinical Trials.
Clin Pharmacol Ther 111: 995-1000.
Text

Seitz R, Gürtler L, Schramm W (2021): COVID-19 Convalescent Plasma: No Definite Answer Yet.
J Blood Lymph 11: 265.
Text

Anzaghe M, Kronhart S, Niles MA, Höcker L, Dominguez M, Kochs G, Waibler Z (2021): Type I interferon receptor-independent interferon-α induction upon infection with a variety of negative-strand RNA viruses.
J Gen Virol 102: 001616.
Text

Araujo-Fernandez I, Delgado J, Moscetti L, Sarac SB, Zander H, Müller-Egert S, Dunder K, Pean E, Bergmann L, Enzmann H, Pignatti F (2021): The European Medicines Agency review of the initial application of atezolizumab and the role of PD-L1 expression as biomarker for checkpoint inhibitors.
ESMO Open 6: 100008.
Online-Abstract

Behr-Gross ME, Regourd E, Holtkamp W (2022): Collaborative study for the establishment of Ph. Eur. Human immunoglobulin for electrophoresis BRP batch 4.
Pharmeur Bio Sci Notes 2022: 37-54.
Online-Abstract

Blanco-Pérez F, Gonzalez-Menendez I, Stassen M, Kato Y, Laiño J, Kirberg J, Krause M, Martella M, Shibata N, Quintanilla-Martinez L, Feyerabend TB, Rodewald HR, Galli SJ, Vieths S, Scheurer S, Toda M (2022): Mast cells partly contribute to allergic enteritis development: findings in two different mast cell-deficient mice.
Allergy 77: 1051-1054.
Online-Abstract

Chansard A, Dubrulle N, Poujol de Molliens M, Falanga PB, Stephen T, Hasan M, van Zandbergen G, Aulner N, Shorte SL, David-Watine B, Milieu Intérieur Consortium (2021): Corrigendum: Unveiling Interindividual Variability of Human Fibroblast Innate Immune Response Using Robust Cell-Based Protocols.
Front Immunol 12: 685768.
Text

Chansard A, Dubrulle N, Poujol de Molliens M, Falanga PB, Stephen T, Hasan M, van Zandbergen G, Aulner N, Shorte SL, David-Watine B (2021): Unveiling Interindividual Variability of Human Fibroblast Innate Immune Response Using Robust Cell-Based Protocols.
Front Immunol 11: 569331.
Text

Chanyalew M, Abebe M, Endale B, Girma S, Tasew G, Bobosha K, Zewide M, Howe R, van Zandbergen G, Ritter U, Gadisa E, Aseffa A, Laskay T (2021): Enhanced activation of blood neutrophils and monocytes in patients with Ethiopian localized cutaneous leishmaniasis in response to Leishmania aethiopica Neutrophil activation in Ethiopian cutaneous leishmaniasis.
Acta Trop 220: 105967.
Online-Abstract

Chanyalew M, Abebe M, Endale B, Girma S, Tasew G, van Zandbergen G, Ritter U, Gadisa E, Aseffa A, Laskay T (2021): Enhanced production of pro-inflammatory cytokines and chemokines in Ethiopian cutaneous leishmaniasis upon exposure to Leishmania aethiopica.
Cytokine 145: 155289.
Online-Abstract

Ebenig A, Muraleedharan S, Kazmierski J, Todt D, Auste A, Anzaghe M, Gömer A, Postmus D, Gogesch P, Niles M, Plesker R, Miskey C, Gellhorn Serra M, Breithaupt A, Hörner C, Kruip C, Ehmann R, Ivics Z, Waibler Z, Pfaender S, Wyler E, Landthaler M, Kupke A, Nouailles G, Goffinet C, Brown RJP, Mühlebach MD (2022): Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after TH2-biased immunization.
Cell Rep 40: 111214.
Online-Abstract

Gogesch P, Dudek S, van Zandbergen G, Waibler Z, Anzaghe M (2021): The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies.
Int J Mol Sci 22: 8947.
Text

Krause M, Crauwels P, Blanco Pérez F, Globisch M, Wangorsch A, Henle T, Lidholm J, van Zandbergen G, Vieths S, Scheurer S, Toda M (2021): Human monocyte-derived type 1 and 2 macrophages recognize Ara h 1, a major peanut allergen, by different mechanisms.
Sci Rep 11: 10141.
Text

Krauter S, Buescher N, Bräuchle E, Ortega Iannazzo S, Penner I, Krämer N, Gogesch P, Thomas S, Kreutz M, Dejung M, Freiwald A, Butter F, Waibler Z, Plachter B (2022): An Attenuated Strain of Human Cytomegalovirus for the Establishment of a Subviral Particle Vaccine.
Vaccines (Basel) 10: 1326.
Text

Lin YJ, Papp G, Miskey C, Fiedler A, Goretzki S, Wolfheimer S, Crauwels P, Ivics Z, van Zandbergen G, Vieths S, Scheurer S, Schülke S (2021): The flagellin:allergen fusion protein rFlaA:Betv1 induces a MyD88- and MAPK-dependent activation of glucose metabolism in macrophages.
Cells 10: 2614.
Online-Abstract

Miller L, Waibler Z, Regourd E, Jouette S (2022): Collaborative study for the establishment of Human immunoglobulin for anticomplementary activity BRP replacement batches 3, 4, 5 and 6.
Pharmeur Bio Sci Notes 2022: 10-21.
Online-Abstract

Niles MA, Gogesch P, Kronhart S, Ortega Iannazzo S, Kochs G, Waibler Z, Anzaghe M (2021): Macrophages and dendritic cells are not the major source of pro-inflammatory cytokines upon SARS-CoV-2 infection.
Front Immunol 12: 647824.
Online-Abstract

Njeru SN, Muema JM (2021): In vitro cytotoxicity of Aspilia pluriseta Schweinf. extract fractions.
BMC Res Notes 14: 57.
Text

Peng R, Wang CK, Wang-Kan X, Idorn M, Kjaer M, Zhou FY, Fiil BK, Timmermann F, Orozco SL, McCarthy J, Leung CS, Lu X, Bagola K, Rehwinkel J, Oberst A, Maelfait J, Paludan SR, Gyrd-Hansen M (2022): Human ZBP1 induces cell death-independent inflammatory signaling via RIPK3 and RIPK1.
EMBO Rep 23: e55839.
Online-Abstract

Rossmann L, Bagola K, Stephen T, Gerards AL, Walber B, Ullrich A, Schülke S, Kamp C, Spreitzer I, Hasan M, David-Watine B, Shorte S, Bastian M, van Zandbergen G (2021): Distinct single-component adjuvants steer human DC-mediated T-cell polarization via Toll-like receptor signaling toward a potent antiviral immune response.
Proc Natl Acad Sci U S A 118: e2103651118.
Online-Abstract

Schwarz R, Zitzow E, Fiebig A, Hering S, Humboldt Y, Schoenwaelder N, Kämpfer N, Volkmar K, Hinz B, Kreikemeyer B, Maletzki C, Fiedler T (2022): PEGylation increases antitumoral activity of arginine deiminase of Streptococcus pyogenes.
Appl Microbiol Biotechnol 106: 261-271.
Online-Abstract

Starokozhko V, Kallio M, Kumlin Howell A, Makinen Salmi A, Andrew-Nielsen G, Goldammer M, Burggraf M, Löbker W, Böhmer A, Agricola E, de Vries CS, Pasmooij AMG, Mol PGM, STARS consortium (2021): Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap.
Drug Discov Today 26: 283-288.
Text

Trullas A, Delgado J, Genazzani A, Müller-Berghaus J, Migali C, Müller-Egert S, Zander H, Enzmann H, Pignatti F (2021): The EMA assessment of pembrolizumab as monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer.
ESMO Open 6: 100145.
Text

Albinger N, Hartmann J, Ullrich E (2021): Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany.
Gene Ther 28: 513-527.
Text

Anliker B, Childs L, Rau J, Renner M, Schüle S, Schuessler-Lenz M, Sebe A (2022): Regulatory Considerations for Clinical Trial Applications with CRISPR-Based Medicinal Products.
CRISPR J 5: 364-376.
Online-Abstract

Bexte T, Botezatu L, Miskey C, Reindl LM, Campe J, Mertlitz S, Gebel V, Schubert R, Cremer A, Rettinger E, Prommersberger S, Penack O, Wels WS, Hudecek M, Ivics Z, Ullrich E (2022): High antileukemic efficiency of CD19-CAR NK cells engineered with Sleeping Beauty transposon vectors.
Klin Padiatr 234: 190-191.
Online-Abstract

Bold CS, Baltissen D, Ludewig S, Back MK, Just J, Kilian L, Erdinger S, Banicevic M, Rehra L, Almouhanna F, Nigri M, Wolfer DP, Spilger R, Rohr K, Kann O, Buchholz CJ, von Engelhardt J, Korte M, Müller UC (2022): APPsα Rescues Tau-Induced Synaptic Pathology.
J Neurosci 42: 5782-5802.
Online-Abstract

Büning H, Fehse B, Ivics Z, Kochanek S, Koehl U, Kupatt C, Mussolino C, Nettelbeck DM, Schambach A, Uckert W, Wagner E, Cathomen T (2021): Gene Therapy "Made in Germany": A Historical Perspective, Analysis of the Status Quo, and Recommendations for Action by the German Society for Gene Therapy.
Hum Gene Ther 32: 987-996.
Online-Abstract

Charitidis FT, Adabi E, Thalheimer FB, Clarke C, Buchholz CJ (2021): Monitoring CAR T cell generation with a CD8-targeted lentiviral vector by single-cell transcriptomics.
Mol Ther Methods Clin Dev 23: 359-369.
Online-Abstract

Donnadieu E, Luu M, Alb M, Anliker B, Arcangeli S, Bonini C, De Angelis B, Choudhary R, Espie D, Galy A, Holland C, Ivics Z, Kantari-Mimoun C, Kersten MJ, Köhl U, Kuhn C, Laugel B, Locatelli F, Marchiq I, Markman J, Moresco MA, Morris E, Negre H, Quintarelli C, Rade M, Reiche K, Renner M, Ruggerio E, Sanges C, Stauss H, Themeli M, Van den Brulle J, Hudecek M, Casucci M (2022): Time to evolve: predicting engineered T cell-associated toxicity with next-generation models.
J Immunother Cancer 10: e003486.
Text

Droste A, Chaves G, Stein S, Trzmiel A, Schweizer M, Karl H, Musset B (2021): Zinc accelerates respiratory burst termination in human PMN.
Redox Biol 47: 102133.
Text

Ebenig A, Muraleedharan S, Kazmierski J, Todt D, Auste A, Anzaghe M, Gömer A, Postmus D, Gogesch P, Niles M, Plesker R, Miskey C, Gellhorn Serra M, Breithaupt A, Hörner C, Kruip C, Ehmann R, Ivics Z, Waibler Z, Pfaender S, Wyler E, Landthaler M, Kupke A, Nouailles G, Goffinet C, Brown RJP, Mühlebach MD (2022): Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after TH2-biased immunization.
Cell Rep 40: 111214.
Online-Abstract

Fischer N, Gulich B, Tönjes RR, Godehardt AW (2022): Limited environmental stability of infectious porcine endogenous retrovirus type C; Usage of reverse transcriptase in combination with viral RNA as markers for infectious virus.
Xenotransplantation 29: e12738.
Text

Fukuda S, Varshney A, Fowler BJ, Wang S, Narendran S, Ambati K, Yasuma T, Magagnoli J, Leung H, Hirahara S, Nagasaka Y, Yasuma R, Apicella I, Pereira F, Makin RD, Magner E, Liu X, Sun J, Wang M, Baker K, Marion KM, Huang X, Baghdasaryan E, Ambati M, Ambati VL, Pandey A, Pandya L, Cummings T, Banerjee D, Huang P, Yerramothu P, Tolstonog GV, Held U, Erwin JA, Paquola ACM, Herdy JR, Ogura Y, Terasaki H, Oshika T, Darwish S, Singh R, Mozaffari S, Bhattarai D, Kim KY, Hardin JW, Bennett CL, Hinton DR, Hanson TE, Röver C, Parang K, Kerur N, Liu J, Werner BC, Sutton SC, Sadda SR, Schumann GG, Gelfand BD, Gage FH, Ambati J (2021): Cytoplasmic synthesis of endogenous Alu complementary DNA via reverse transcription and implications in age-related macular degeneration.
Proc Natl Acad Sci U S A 118: e2022751118.
Text

Gasparics Á, Sebe A (2022): Forward Genetic Screens as Tools to Investigate Role and Mechanisms of EMT in Cancer.
Cancers (Basel) 14: 5928.
Text

Guedan S, Luu M, Ammar D, Barbao P, Bonini C, Bousso P, Buchholz CJ, Casucci M, De Angelis B, Donnadieu E, Espie D, Greco B, Groen R, Huppa JB, Kantari-Mimoun C, Laugel B, Mantock M, Markman JL, Morris E, Quintarelli C, Rade M, Reiche K, Rodriguez-Garcia A, Rodriguez-Madoz JR, Ruggiero E, Themeli M, Hudecek M, Marchiq I (2022): Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?.
J Immunother Cancer 10: e003487.
Text

Heim C, Moser LM, Merker M, Wels WS, Ivics Z, Bönig H, Ullrich E, Klusmann JH, Bader P, Rettinger E (2022): ErbB2-CAR mediated immunotherapy for the treatment of high-risk rhabdomyosarcoma.
Klin Padiatr 234: 190.
Online-Abstract

Irving M, Lanitis E, Migliorini D, Ivics Z, Guedan S (2021): Choosing the Right Tool for Genetic Engineering: Clinical Lessons from Chimeric Antigen Receptor-T Cells.
Hum Gene Ther 32: 1044-1058.
Text

Ivics Z (2021): Potent CAR-T Cells Engineered With Sleeping Beauty Transposon Vectors Display a Central Memory Phenotype.
Gene Ther 28: 3-5.
Online-Abstract

Jia W, Asare E, Liu T, Zhang P, Wang Y, Wang s, Shen D, Miskey C, Gao B, Ivics Z, Qian Q, Song C (2022): Horizontal Transfer and Evolutionary Profiles of Two Tc1/ DD34E Transposons ( ZB and SB) in Vertebrates.
Genes (Basel) 13: 2239.
Text

Johnen S, Harmening N, Marie C, Scherman D, Izsvák Z, Ivics Z, Walter P, Thumann G (2021): Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells using the Sleeping Beauty Transposon System.
J Vis Exp: e61987.
Online-Abstract

Lapaillerie D, Lelandais B, Mauro E, Lagadec F, Tumiotto C, Miskey C, Ferran G, Kuschner N, Calmels C, Métifiot M, Rooryck C, Ivics Z, Ruff M, Zimmer C, Lesbats P, Toutain J, Parissi V (2021): Modulation of the intrinsic chromatin binding property of HIV-1 integrase by LEDGF/p75.
Nucleic Acids Res 49: 11241-11256.
Text

Lin YJ, Papp G, Miskey C, Fiedler A, Goretzki S, Wolfheimer S, Crauwels P, Ivics Z, van Zandbergen G, Vieths S, Scheurer S, Schülke S (2021): The flagellin:allergen fusion protein rFlaA:Betv1 induces a MyD88- and MAPK-dependent activation of glucose metabolism in macrophages.
Cells 10: 2614.
Online-Abstract

Michels A, Frank AM, Günther DM, Mataei M, Börner K, Grimm D, Hartmann J, Buchholz CJ (2021): Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8.
Mol Ther Methods Clin Dev 23: 334-347.
Online-Abstract

Michels A, Ho N, Buchholz CJ (2022): Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platforms.
Mol Ther 30: 2401-2415.
Text

Miskei M, Horváth A, Viola L, Varga L, Nagy E, Feró O, Karányi Z, Roszik J, Miskey C, Ivics Z, Székvölgyi L (2021): Genome-wide mapping of binding sites of the transposase-derived SETMAR protein in the human genome.
Comput Struct Biotechnol J 19: 4032-4041.
Online-Abstract

Miskey C, Botezatu L, Temiz NA, Gogol-Doring A, Bartha A, Gyorffy B, Largaespada DA, Ivics Z, Sebe A (2022): In Vitro Insertional Mutagenesis Screen Identifies Novel Genes Driving Breast Cancer Metastasis.
Mol Cancer Res 20: 1502-1515.
Online-Abstract

Miskey C, Kesselring L, Querques I, Abrusán G, Barabas O, Ivics Z (2022): Engineered Sleeping Beauty transposase redirects transposon integration away from genes.
Nucleic Acids Res 50: 2807-2825.
Text

Ochmann MT, Ivics Z (2021): Jumping Ahead with Sleeping Beauty: Mechanistic Insights into Cut-and-Paste Transposition.
Viruses 13: 76.
Text

Prommersberger S, Reiser M, Beckmann J, Danhof S, Amberger M, Quade-Lyssy P, Hermann Einsele H, Hudecek M, Bonig H, Ivics Z (2021): CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma.
Gene Ther 28: 560-571.
Online-Abstract

Reindl LM, Albinger N, Bexte T, Müller S, Hartmann J, Ullrich E (2021): Immunotherapy with NK cells: recent developments in gene modification open up new avenues.
Oncoimmunology 9: 1777651.
Text

Sandoval-Villegas N, Nurieva W, Amberger M, Ivics Z (2021): Contemporary Transposon Tools: A Review and Guide through Mechanisms and Applications of Sleeping Beauty, piggyBac and Tol2 for Genome Engineering.
Int J Mol Sci 22: 5084.
Text

Savage AL, Iacoangeli A, Schumann GG, Rubio-Roldan A, Garcia-Perez JL, Al Khleifat A, Koks S, Bubb VJ, Al-Chalabi A, Quinn JP (2022): Characterisation of retrotransposon insertion polymorphisms in whole genome sequencing data from individuals with amyotrophic lateral sclerosis.
Gene 843: 146799.
Online-Abstract

Schöbel A, Nguyen-Dinh V, Schumann GG, Herker E (2021): Hepatitis C virus infection restricts human LINE-1 retrotransposition in hepatoma cells.
PLoS Pathog 17: e1009496.
Text

Schüßler-Lenz M, Scherer J, Müller-Berghaus J (2022): Arzneimittel für neuartige Therapien (ATMP): Ankunft in der Versorgung.
Pharmakon 10: 337-343.
Text

Shen D, Song C, Miskey C, Chan S, Guan Z, Sang Y, Wang Y, Chen C, Wang X, Müller F, Ivics Z, Gao B (2021): A native, highly active Tc1/mariner transposon from zebrafish (ZB) offers an efficient genetic manipulation tool for vertebrates.
Nucleic Acids Res 49: 2126-2140.
Text

Strecker MI, Wlotzka K, Strassheimer F, Roller B, Ludmirski G, König S, Röder J, Opitz C, Alekseeva T, Reul J, Sevenich L, Tonn T, Wels WS, Steinbach JP, Buchholz CJ, Burger MC (2022): AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma.
Oncoimmunology 11: e2127508.
Text

Tegtmeyer B, Vieyres G, Todt D, Lauber C, Ginkel C, Engelmann M, Herrmann M, Pfaller CK, Vondran FWR, Broering R, Vafadarnejad E, Saliba AE, Puff C, Baumgärtner W, Miskey C, Ivics Z, Steinmann E, Pietschmann T, Brown RJP (2021): Initial HCV infection of adult hepatocytes triggers a temporally structured transcriptional program containing diverse pro- and anti-viral elements.
J Virology 95: e00245-21.
Online-Abstract

Theuerkauf SA, Michels A, Riechert V, Maier TJ, Flory E, Cichutek K, Buchholz CJ (2021): Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without.
iScience 24: 102170.
Online-Abstract

Wachtl G, Schád É, Huszár K, Palazzo A, Ivics Z, Tantos Á, Orbán TI (2022): Functional Characterization of the N-Terminal Disordered Region of the piggyBac Transposase.
Int J Mol Sci 23: 10317.
Text

Weidner T, Agarwal S, Perian S, Fusil F, Braun G, Hartmann J, Verhoeyen E, Buchholz CJ (2021): Genetic in vivo engineering of human T lymphocytes in mouse models.
Nat Protoc 16: 3210-3240.
Text

Zahn T, Mhedhbi I, Hein S, Raupach J, Miskey C, Husria Y, Bayanga K, Bartel D, Vieths S, Ivics Z, Oberle D, Keller-Stanislawski K, Herrlein ML, Maier TJ, Hildt E (2022): Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19.
Allergy 77: 2053-2066.
Online-Abstract

Alirezaeizanjani Z, Trösemeier JH, Kamp C, Rudorf S (2022): Tailoring Codon Usage to the Underlying Biology for Protein Expression Optimization.
Methods Mol Biol 2406: 85-92.
Online-Abstract

Arrazuria R, Kerscher B, Huber KE, Hoover JL, Lundberg CV, Hansen JU, Sordello S, Renard S, Aranzana-Climent V, Hughes D, Gribbon P, Friberg LE, Bekeredjian-Ding I (2022): Expert workshop summary: Advancing toward a standardized murine model to evaluate treatments for antimicrobial resistance lung infections.
Front Microbiol 13: 988725.
Text

Arrazuria R, Kerscher B, Huber KE, Hoover JL, Lundberg CV, Hansen JU, Sordello S, Renard S, Aranzana-Climent V, Hughes D, Gribbon P, Friberg LE, Bekeredjian-Ding I (2022): Variability of murine bacterial pneumonia models used to evaluate antimicrobial agents.
Front Microbiol 13: 988728.
Text

Etna MP, Signorazzi A, Ricci D, Severa M, Rizzo F, Giacomini E, Gaggioli A, Bekeredjian-Ding I, Huckriede A, Coccia EM (2021): Human plasmacytoid dendritic cells at the crossroad of type I interferon-regulated B cell differentiation and antiviral response to tick-borne encephalitis virus.
PLoS Pathog 17: e1009505.
Online-Abstract

Etscheid M, Hanschmann KM, Sandset PM, Kanse SM (2022): Development of a Factor VII Activating Protease (FSAP) generation assay and its application in studying FSAP in venous thrombosis.
Thromb Res 220: 24-34.
Online-Abstract

Jepsen K, Falk W, Brune F, Cosgarea R, Fimmers R, Bekeredjian-Ding I, Jepsen S (2022): Prevalence and Antibiotic Susceptibility Trends of Selected Enterobacteriaceae, Enterococci, and Candida albicans in the Subgingival Microbiota of German Periodontitis Patients: A Retrospective Surveillance Study.
Antibiotics (Basel) 11: 385.
Text

Jepsen K, Falk W, Brune F, Fimmers R, Jepsen S, Bekeredjian-Ding I (2021): Prevalence and antibiotic susceptibility trends of periodontal pathogens in the subgingival microbiota of German periodontitis patients: A retrospective surveillance study.
J Clin Periodontal 48: 1216-1227.
Online-Abstract

Kamp C, Becker B, Matheis W, Öppling V, Bekeredjian-Ding I (2021): How to draw the line - Raman spectroscopy as a tool for the assessment of biomedicines.
Biol Chem 402: 1001-1006.
Online-Abstract

Klimka A, Mertins S, Nicolai AK, Rummler LM, Higgins PG, Günther SD, Tosetti B, Krut O, Krönke M (2021): Epitope-specific immunity against Staphylococcus aureus coproporphyrinogen III oxidase.
NPJ Vaccines 6: 11.
Text

Lasch F, Guizzaro L, Aguirre Dávila L, Müller-Vahl K, Koch A (2021): Potential impact of COVID-19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA-TICS study.
Pharm Stat 20: 675-691.
Online-Abstract

Miranda-García MA, Hoffelner M, Stoll H, Ruhaltinger D, Cichutek K, Siedler A, Bekeredjian-Ding I (2022): A 5-year look-back at the notification and management of vaccine supply shortages in Germany.
Euro Surveill 27: 2100167.
Text

Prax M, Spindler-Raffel E, McDonald CP, Bearne J, Satake M, Kozakai M, Rojo J, Hanschmann KO, Lambrecht B, Grundmann U, O'Flaherty N, Klimek A, Bekeredjian-Ding I, Gathof BS, Störmer M, Süßner S, Renke C, Lee CK, Knabbe C, Volllmer T, Keil SD, Shipps ME, Wagner SJ, Jentsch U, Mpumlwana X, Cloutier M, Bringmann P, Lu T, Ramirez-Arcos S, Kou Y, Krut O, ISBT Transfusion-Transmitted Infectious Diseases Working Party, Subgroup on Bacteria (2021): Establishment of Transfusion-Relevant Bacteria Reference Strains for Red Blood Cells.
Vox Sang 116: 692-701.
Text

Rodriguez-Rodriguez N, Clark PA, Gogoi M, Ferreira ACF, Kerscher B, Crisp A, Jolin HE, Murphy JE, Sivasubramaniam M, Pedro L, Walker JA, Heycock MWD, Shields JD, Barlow JL, McKenzie ANJ (2022): Identification of aceNKPs, a committed common progenitor population of the ILC1 and NK cell continuum.
Proc Natl Acad Sci USA 119: e2203454119.
Text

Roig MB, Krotka P, Burman CF, Glimm E, Gold SM, Hees K, Jacko P, Koenig F, Magirr D, Mesenbrink P, Viele K, Posch M (2022): On model-based time trend adjustments in platform trials with non-concurrent controls.
BMC Med Res Methodol 22: 228.
Text

Srivastav S, Dankov A, Adanalic M, Grzeschik R, Tran V, Pagel-Wieder S, Gessler F, Spreitzer I, Scholz T, Schnierle B, Anastasiou OE, Dittmer U, Schlücker S (2021): Rapid and Sensitive SERS-Based Lateral Flow Test for SARS-CoV2-Specific IgM/IgG Antibodies.
Anal Chem 93: 12391-12399.
Online-Abstract

Tichá O, Klemm D, Moos L, Bekeredjian-Ding I (2021): A cell-based in vitro assay for testing of immunological integrity of Tetanus toxoid vaccine antigen.
NPJ Vaccines 6: 88.
Text

Ticha O, Moos L, Bekeredjian-Ding I (2021): Effects of long-term cryopreservation of PBMC on recovery of B cell subpopulations.
J Immunol Methods 495: 113081.
Text

Ticha O, Slanina P, Moos L, Stichova J, Vlkova M, Bekeredjian-Ding I (2021): TNFR2 expression is a hallmark of human memory B cells with suppressive function.
Eur J Immunol 51.
Text

Tosetti B, Ward B, Grumme D, Herb M, Schramm M, Utermöhlen O, Heukamp LC, Krönke M, Krut O (2021): NOX2 Deficiency Permits Sustained Survival of S. aureus in Macrophages and Contributes to Severity of Infection.
Front Immunol 12: 633629.
Text

Wöhrle F, Kerscher B, Cicin-Sain L, Bekeredjian-Ding I (2022): DGfI Study Group Vaccines - Annual Meeting 2022.
Eur J Immunol 52: 370-371.
Text

Aghilipour H, Fiedler S, Funk MB (2022): Zuständigkeiten des Paul-Ehrlich-Instituts auf der Basis der neuen EU-Verordnung für In-vitro-Diagnostika.
Bulletin zur Arzneimittelsicherheit 13: 9-15.
Text

Berg P, Schönefeld S, Ruppert-Seipp G, Funk MB (2022): Regulatory Measures to Improve the Safety of CAR-T-Cell Treatment.
Transfus Med Hemother 50: 218-225.
Text

Bergner S, Grüger T, Huber M, Lütkehermölle W, Paeschke N, Palissa H, Stephan K, Cibura S, Keller-Stanislawski B (2022): Instrumente behördlicher Kommunikation zu Anwendungsrisiken von Arzneimitteln.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65: 567-576.
Text

Breitenbach T, Englert N, Osmanoglu Ö, Rukoyatkina N, Wangorsch G, Heinze K, Friebe A, Butt E, Feil R, Dittrich M, Gambaryan S, Dandekar T (2022): A modular systems biological modelling framework studies cyclic nucleotide signaling in platelets.
J Theor Biol 550: 111222.
Text

Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S (2021): Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
N Engl J Med 384: 2092-2101.
Text

Guimaraes Koch SS, Thorpe R, Kawasaki N, Lefranc MP, Malan S, Martin ACR, Mignot G, Plückthun A, Rizzi M, Shubat S, Weisser K, Balocco R (2022): International nonproprietary names for monoclonal antibodies: an evolving nomenclature system.
MAbs 14: 2075078.
Online-Abstract

Hassan M, Krieg SC, Ndefo Nde C, Roos J, Maier TJ, El Rady EA, Raslan MA, Sadek KU, Manolikakes G (2021): Streamlined One-Pot Synthesis of Nitro Fatty Acids.
Eur JOC 2021: 2239-2252.
Text

Hein S, Benz NI, Eisert J, Herrlein ML, Oberle D, Dreher M, Stingl JC, Hildt C, Hildt E (2021): Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes.
Vaccines (Basel) 9: 1419.
Online-Abstract

Hein S, Mhedhbi I, Zahn T, Sabino C, Benz NI, Husria Y, Renelt PM, Braun F, Oberle D, Maier TJ, Hildt C, Hildt E (2022): Quantitative and Qualitative Difference in Antibody Response against Omicron and Ancestral SARS‐CoV‐2 after Third and Fourth Vaccination.
Vaccines (Basel) 10: 796.
Text

Heinzerling L, La Rosée P, Gutzmer R, Kramer R, Keller-Stanislawski B, Zierold S, Mentzer D (2021): Response to letter entitled: 'Re: Hematological immune related adverse events after treatment with immune checkpoint inhibitors.
Eur J Cancer 153: 272-273.

Hellmuth N, Brat C, Awad O, George S, Kahnt A, Bauer T, Huynh Phuoc HP, Steinhilber D, Angioni C, Hassan M, Hock KJ, Manolikakes G, Zacharowski K, Roos J, Maier TJ (2021): Structural Modifications Yield Novel Insights Into the Intriguing Pharmacodynamic Potential of Anti-inflammatory Nitro-Fatty Acids.
Front Pharmacol 12: 715076.
Text

Hethey C, Hartung N, Wangorsch G, Weisser K, Huisinga W (2021): Physiology-based toxicokinetic modelling of aluminium in rat and man.
Arch Toxicol 95: 2977-3000.
Online-Abstract

Kahnt AS, Angioni C, Göbel T, Hofmann B, Roos J, Steinbrink SD, Rörsch F, Thomas D, Geisslinger G, Zacharowski K, Grösch S, Steinhilber D, Maier TJ (2022): Inhibitors of Human 5-Lipoxygenase Potently Interfere With Prostaglandin Transport.
Front Pharmacol 12: 782584.
Text

Kehr S, Berg P, Müller S, Fiedler SA, Meyer B, Ruppert-Seipp G, Witzenhausen C, Wolf ME, Henkes HH, Oberle D, Keller-Stanislawski B, Funk MB (2022): Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis.
NPJ Vaccines 7: 76.
Online-Abstract

Keipert C, Drechsel-Bäuerle U, Oberle D, Müller-Olling M, Hilger A (2021): Epidemiological Challenges in Rare Bleeding Disorders: FVIII Inhibitor Incidence in Haemophilia A Patients - A Known Issue of Unknown Origin.
Int J Environ Res Public Health 18: 225.
Online-Abstract

Mentzer D, Keller-Stanislawski B (2022): Verdachtsfälle von Nebenwirkungen und Impfkomplikationen nach Impfung mit Comirnaty® bei Kindern im Alter von 5–11 Jahren aus Deutschland: Meldungen an das Paul-Ehrlich-Institut bis zum 03.03.2022.
Bulletin zur Arzneimittelsicherheit 13: 15-21.
Text

Mentzer D, Keller-Stanislawski B (2022): Verdachtsfälle von Nebenwirkungen oder Impfkomplikationen nach Impfung mit den Omikron-adaptierten bivalenten COVID-19-Impfstoffen Comirnaty Original/Omicron BA.1, Comirnaty Original/Omicron BA.4-5, Spikevax bivalent/ Omicron BA.1 (bis 31.10.2022 in Deutschland gemeldet).
Bulletin zur Arzneimittelsicherheit 13: 29-34.
Text

Miranda-García MA, Hoffelner M, Stoll H, Ruhaltinger D, Cichutek K, Siedler A, Bekeredjian-Ding I (2022): A 5-year look-back at the notification and management of vaccine supply shortages in Germany.
Euro Surveill 27: 2100167.
Text

Mitterreiter J, Scheiblauer H, Fiedler S, Kreß J (2022): Sicherheit von Blut und Blutprodukten: Testmethoden zum Nachweis der Hepatitisviren B, C und E.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65: 209-219.
Text

Mönch K, Streit R, Keller-Stanislawski B (2022): Nuvaxovid® – gemeldete Verdachtsfälle von Nebenwirkungen in den ersten drei Monaten seit Beginn der Impfungen mit diesem Impfstoff.
Bulletin zur Arzneimittelsicherheit 13: 27-30.
Text

Müller S, Buchholz CJ, Funk M, Keller-Stanislawski B (2021): Überprüfung des Leukämierisikos bei der Behandlung der Beta-Thalassämie mit dem Gentherapeutikum Zynteglo® – europäisches Risikoverfahren (Referral Procedure, Article 20 of Regulation (EC) No 726/2004).
Bulletin zur Arzneimittelsicherheit 12: 4-9.
Text

Musuamba FT, Skottheim Rusten I, Lesage R, Russo G, Bursi R, Emili L, Wangorsch G, Manolis E, Karlsson KE, Kulesza A, Courcelles E, Boissel JP, Rousseau CF, Voisin EM, Alessandrello R, Curado N, Dall'ara E, Rodriguez B, Pappalardo F, Geris L (2021): Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility.
CPT Pharmacometrics Syst Pharmacol 10: 804-825.
Text

Nguyen MTH, Krause G, Keller-Stanislawski B, Glöckner S, Mentzer D, Ott JJ (2021): Postmarketing Safety Monitoring After Influenza Vaccination Using a Mobile Health App: Prospective Longitudinal Feasibility Study.
JMIR Mhealth Uhealth 9: e26289.
Text

Orru' S, Poetzsch K, Hoffelner M, Heiden M, Funk MB, Keller-Stanislawski B, Oberle D (2021): Unerwünschte Reaktionen bei der Blutspende: Ergebnisse einer Online-Umfrage unter Spenderinnen und Spendern in Deutschland.
Bulletin zur Arzneimittelsicherheit 12: 18-24.
Text

Orru' S, Poetzsch K, Hoffelner M, Heiden M, Funk MB, Keller-Stanislawski B, Oberle D (2021): Blood Donation-Related Adverse Reactions: Results of an Online Survey among Donors in Germany (2018).
Transfus Med Hemother 48: 272-283.
Text

Richter E, Al Arashi D, Schulte B, Bode C, Marx B, Aldabbagh S, Schlüter C, Kümmerer BM, Oldenburg J, Funk MB, Putensen C, Schmithausen RM, Hartmann G, Eis-Hübinger A, Streeck H (2021): Detectable SARS-CoV-2 RNAemia in Critically Ill Patients, but Not in Mild and Asymptomatic Infections.
Transfus Med Hemother 48: 154-159.
Text

Robertson JS, Loizides U, Adisa A, López de la Rica Manjavacas A, Rodilla V, Strnadova C, Weisser K, Balocco R (2022): International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety.
Vaccine 40: 21-27.
Online-Abstract

Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C (2022): Antibody response to SARS-CoV-2 for more than one year − kinetics and persistence of detection are predominantly determined by avidity progression and test design.
J Clin Virol 146: 105052.
Text

Thiele T, Weisser K, Schönborn L, Funk MB, Weber G, Greinacher A, Keller-Stanislawski K (2022): Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany.
Lancet Reg Health Eur 12: 100270.
Online-Abstract

Wagner R, Hildt E, Grabski E, Sun Y, Meyer H, Lommel A, Keller-Stanislawski B, Müller-Berghaus J, Cichutek K (2021): Accelerated Development of COVID-19 Vaccines: Technology Platforms, Benefits, and Associated Risks.
Vaccines (Basel) 9: 747.
Text

Weisser K (2022): Abschied von „-mab“– neue internationale Freinamen (INN) für monoklonale Antikörper.
Bulletin zur Arzneimittelsicherheit 13: 31-35.
Text

Weisser K, Kling K, Huth C, Keller-Stanislawski B, Mahler V (2021): Was ist bei positiver Allergieanamnese vor einer Impfung gegen COVID-19 zu beachten?.
Bulletin zur Arzneimittelsicherheit 12: 23-26.
Text

Zahn T, Mhedhbi I, Hein S, Raupach J, Miskey C, Husria Y, Bayanga K, Bartel D, Vieths S, Ivics Z, Oberle D, Keller-Stanislawski K, Herrlein ML, Maier TJ, Hildt E (2022): Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19.
Allergy 77: 2053-2066.
Online-Abstract

Auste A, Mühlebach MD (2022): Concentrating all helper protein functions on a single entity allows rescue of recombinant measles virus by transfection of just two plasmids.
J Gen Virol 103: 001815.
Text

de Alwis R, Zellweger RM, Chua E, Wang LF, Chawla T, Sessions OM, Marlier D, Connolly JE, von Messling V, Anderson DE (2021): Systemic inflammation, innate immunity and pathogenesis after Zika virus infection in cynomolgus macaques are modulated by strain-specificity within the Asian lineage.
Emerg Microbes Infect 10: 1457-1470.
Online-Abstract

Ding L, Li J, Li X, Qu B (2022): Evolutionary and Mutational Characterization of the First H5N8 Subtype Influenza A Virus in Humans.
Pathogens 11: 666.
Text

Ebenig A, Lange MV, Mühlebach MD (2022): Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines.
NPJ Vaccines 7: 119.
Online-Abstract

Ebenig A, Muraleedharan S, Kazmierski J, Todt D, Auste A, Anzaghe M, Gömer A, Postmus D, Gogesch P, Niles M, Plesker R, Miskey C, Gellhorn Serra M, Breithaupt A, Hörner C, Kruip C, Ehmann R, Ivics Z, Waibler Z, Pfaender S, Wyler E, Landthaler M, Kupke A, Nouailles G, Goffinet C, Brown RJP, Mühlebach MD (2022): Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after TH2-biased immunization.
Cell Rep 40: 111214.
Online-Abstract

Fekadu J, Modlich U, Bader P, Bakhtiar S (2022): Understanding the Role of LFA-1 in Leukocyte Adhesion Deficiency Type I (LAD I): Moving towards Inflammation?.
Int J Mol Sci 23: 3578.
Online-Abstract

Gömer A, Brown RJP, Pfaender S, Deterding K, Reuter G, Orton R, Seitz S, Bock CT, Cavalleri JMV, Pietschmann T, Wedemeyer H, Steinmann E, Todt D (2022): Intra-host analysis of hepaciviral glycoprotein evolution reveals signatures associated with viral persistence and clearance.
Virus Evol 8: veac007.
Text

Hauptstein N, Dirauf M, Wittwer K, Cinar G, Siering O, Raschig M, Lühmann T, Scherf-Clavel O, Sawatsky B, Nischang I, Schubert US, Pfaller CK, Meinel L (2022): PEtOxylated Interferon-α2a Bioconjugates Addressing H1N1 Influenza A Virus Infection.
Biomacromolecules 23: 3593-3601.
Text

Hauptstein N, Pouyan P, Wittwer K, Cinar G, Scherf-Clavel O, Raschig M, Licha K, Lühmann T, Nischang I, Schubert US, Pfaller CK, Haag R, Meinel L (2022): Polymer selection impacts the pharmaceutical profile of site-specifically conjugated Interferon-α2a.
J Control Release 348: 881-892.
Text

Hennrich AA, Sawatsky B, Santos-Mandujano R, Banda DH, Oberhuber M, Schopf A, Pfaffinger V, Wittwer K, Riedel C, Pfaller CK, Conzelmann K (2021): Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization.
PLoS Pathog 17: e1009064.
Online-Abstract

Henss L, Auste A, Schürmann C, Schmidt C, von Rhein C, Mühlebach MD, Schnierle BS (2021): The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection.
J Gen Virol 102: 001574.
Text

Herrmann M, Yampolsky LY (2021): False and true positives in arthropod thermal adaptation candidate gene lists.
Genetica 149: 143-153.
Online-Abstract

Hörner M, Jerez-Longres C, Hudek A, Hook S, Yousefi OS, Schamel WWA, Hörner C, Zurbriggen MD, Ye H, Wagner HJ, Weber W (2021): Spatiotemporally confined red light-controlled gene delivery at single-cell resolution using adeno-associated viral vectors.
Sci Adv 7: eabf0797.
Text

Nettelbeck DM, Leber MF, Altomonte J, Angelova A, Beil J, Berchtold S, Delic M, Eberle J, Ehrhardt A, Engeland CE, Fechner H, Geletneky K, Goepfert K, Holm PS, Kochanek S, Kreppel F, Krutzke L, Kühnel F, Lang KS, Marchini A, Moehler M, Mühlebach MD, Naumann U, Nawroth R, Nüesch J, Rommelaere J, Lauer UM, Ungerechts G (2021): Virotherapy in Germany - Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies.
Viruses 13: 1420.
Text

Pfaller CK, George CX, Samuel CE (2021): Adenosine Deaminases Acting on RNA (ADARs) and Viral Infections.
Annu Rev Virol 8: 239-264.
Online-Abstract

Plesker R, Hintereder G (2021): Spontaneous (Hashimoto-like) chronic lymphocytic thyroiditis in a rhesus macaque (Macaca mulatta).
Primate Biol 8: 37-42.
Text

Pott F, Postmus D, Brown RJP, Wyler E, Neumann E, Landthaler M, Goffinet C (2021): Single-cell analysis of arthritogenic alphavirus-infected human synovial fibroblasts links low abundance of viral RNA to induction of innate immunity and arthralgia-associated gene expression.
Emerg Microbes Infect 10: 2151-2168.
Text

Qu B, Brown RJP (2021): Strategies to Inhibit Hepatitis B Virus at the Transcript Level.
Viruses 13: 1327.
Online-Abstract

Reinecke B, Frericks N, Lauber C, Dinkelborg K, Matthaei A, Vondran FWR, Behrendt P, Haid S, Brown RJP, Pietschmann T (2022): The Human Liver-Expressed Lectin CD302 Restricts Hepatitis C Virus Infection.
J Virol 96: e01995-21.
Text

Rommel MGE, Walz L, Fotopoulou F, Kohlscheen S, Schenk F, Miskey C, Botezatu L, Krebs Y, Voelker IM, Wittwer K, Holland-Letz T, Ivics Z, von Messling V, Essers MAG, Milsom MD, Pfaller CK, Modlich U (2022): Influenza A Virus Infection Instructs Hematopoiesis to Megakaryocyte-lineage Output.
Cell Rep 41: 111447.
Online-Abstract

Schwarzer A, Talbot SR, Selich A, Morgan M, Schott JW, Dittrich-Breiholz O, Bastone AL, Weigel B, Ha TC, Dziadek V, Gijsbers R, Thrasher AJ, Staal FJ, Gaspar HB, Modlich U, Schambach A, Rothe M (2021): Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learning.
Mol Ther 29: 3383-3397.
Online-Abstract

Shin DL, Chludzinski E, Wu NH, Peng JY, Ciurkiewicz M, Sawatsky B, Pfaller CK, Baechlein C, von Messling V, Haas L, Beineke A, Herrler G (2022): Overcoming the Barrier of the Respiratory Epithelium during Canine Distemper Virus Infection.
mBio 13: e0304321.
Online-Abstract

Siering O, Sawatsky B, Pfaller CK (2021): C Protein is Essential for Canine Distemper Virus Virulence and Pathogenicity in Ferrets.
J Virol 95: e01840-20.
Online-Abstract

Siering O, Cattaneo R, Pfaller CK (2022): C Proteins: Controllers of Orderly Paramyxovirus Replication and of the Innate Immune Response.
Viruses 14: 137.
Online-Abstract

Tegtmeyer B, Vieyres G, Todt D, Lauber C, Ginkel C, Engelmann M, Herrmann M, Pfaller CK, Vondran FWR, Broering R, Vafadarnejad E, Saliba AE, Puff C, Baumgärtner W, Miskey C, Ivics Z, Steinmann E, Pietschmann T, Brown RJP (2021): Initial HCV infection of adult hepatocytes triggers a temporally structured transcriptional program containing diverse pro- and anti-viral elements.
J Virology 95: e00245-21.
Online-Abstract

van Heuvel Y, Berg K, Hirch T, Winn K, Modlich U, Stitz J (2021): Establishment of a novel stable human suspension packaging cell line producing ecotropic retroviral MLV(PVC-211) vectors efficiently transducing murine hematopoietic stem and progenitor cells.
J Virol Methods 297: 114243.
Online-Abstract

Wenzel A, Thomas J, Schwedinger E, Wolf R (2022): Pharmakovigilanzreport immunologischer Tierarzneimittel: Analyse der Meldungen unerwünschter Ereignisse in Deutschland aus dem Jahr 2021.
DTBl 70: 1166-1174.
Volltext

Wenzel A, Thomas J, Wolf R (2021): Pharmakovigilanzreport immunologische Tierarzneimittel: Analyse der Nebenwirkungsmeldungen in Deutschland aus dem Jahr 2020.
DTBl 69: 1044-1054.
Volltext

Wittwer K, Anderson DE, Pfeffermann K, Cox RM, Wolf JD, Santibanez S, Mankertz A, Plesker R, Sticher ZM, Kolkykhalov AA, Natchus MG, Pfaller CK, Plemper RK, von Messling V (2021): Small-molecule polymerase inhibitor protects non-human primates from measles and reduces shedding.
Nat Commun 12: 5233.
Text

Woods VMA, Latorre-Rey LJ, Schenk F, Rommel MGE, Moritz T, Modlich U (2022): Targeting transgenic proteins to alpha granules for platelet-directed gene therapy.
Mol Ther Nucleic Acids 27: 774-786.
Text

Zhu S, Stanslowsky N, Fernández-Trillo J, Mamo TM, Yu P, Kalmbach N, Ritter B, Eggenschwiler R, Ouwendijk WJD, Mzinza D, Tan L, Leffler A, Spohn M, Brown RJP, Kropp KA, Kaever V, Ha TC, Narayanan P, Grundhoff A, Förster R, Schambach A, Verjans GMGM, Schmidt M, Kispert A, Cantz T, Gomis A, Wegner F, Viejo-Borbolla A (2021): Generation of hiPSC-derived low threshold mechanoreceptors containing axonal termini resembling bulbous sensory nerve endings and expressing Piezo1 and Piezo2.
Stem Cell Res 56: 102535.
Online-Abstract

Basic M, Kubesch A, Kuhnhenn L, Görgülü E, Finkelmeier F, Dietz J, Knabe M, Mücke VT, Mücke MM, Berger A, Zeuzem S, Sarrazin C, Hildt E, Peiffer KH (2021): Not uncommon: HBV genotype G co-infections among healthy European HBV carriers with genotype A and E infection.
Liver Int 41: 1278-1289.
Online-Abstract

Baylis SA, Adlhoch C, Childs L, and the HEV Sequencing Study Group (2022): An Evaluation of Hepatitis E Virus Molecular Typing Methods.
Clin Chem 68: 181-191.
Text

Baylis SA, Nübling CM (2022): Nucleic Acid Testing of Viral Pathogens: Traceability of the International Unit.
Clin Chem 68: 257-258.
Text

Baylis SA, Nübling CM (2021): Nucleic Acid Testing of Viral Pathogens: Traceability of the International Unit.
Clin Chem 68: 257-258.
Text

Baylis SA, O'Flaherty N, Burke L, Hogema B, Corman VM (2022): Identification of rabbit hepatitis E virus (HEV) and novel HEV clade in Irish blood donors.
J Hepatol 77: 870-872.
Text

Bender D, Glitscher M, Hildt E (2022): Die Virushepatitiden A bis E: Prävalenz, Erregermerkmale und Pathogenese.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65: 139-148.
Text

Bender D, Hildt E (2022): Back to the Roots: Noncanonical Retrograde Trafficking of the HBV Nucleocapsids.
Cell Mol Gastroenterol Hepatol 15: 797-798.
Text

Bernard MC, Waldock J, Commandeur S, Strauß L, Trombetta CM, Marchi S, Zhou F, van de WItte S, van Amsterdam P, Ho S, Hoschler K, Lugovtsev V, Weir JP, Montomoli E, Cox RJ, Engelhardt OG, Friel D, Wagner R, Ollinger T, Germain S, Sediri-Schön H (2022): Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study.
Front Immunol 13: 909297.
Text

Davis CA, Haywood B, Vattipally S, Da Silva Filipe A, AlSaeed M, Smollet K, Baylis SA, Ijaz S, Tedder RS, Thomson EC, Abdelrahman TT (2021): Hepatitis E virus: Whole genome sequencing as a new tool for understanding HEV epidemiology and phenotypes.
J Clin Virol 139: 104738.
Online-Abstract

Glitscher M, Martín DH, Woytinek K, Schmidt B, Tabari D, Scholl C, Stingl JC, Seelow E, Choi M, Hildt E (2021): Targeting cholesterol metabolism as efficient antiviral strategy against the Hepatitis E virus.
Cell Mol Gastroenterol Hepatol 12: 159-180.
Online-Abstract

Glitscher M, Hildt E, Bender D (2022): Hepatitis B und C: Mechanismen der virusinduzierten Leberpathogenese und Tumorentstehung.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65: 228-237.
Text

Glitscher M, Hildt E (2021): Hepatitis E virus egress and beyond - the manifold roles of the viral ORF3 protein.
Cell Microbiol 23: e13379.
Online-Abstract

Glitscher M, Hildt E (2021): Endosomal Cholesterol in Viral Infections - A Common Denominator?.
Front Physiol 12: 750544.
Text

Glitscher M, Himmelsbach K, Woytinek K, Schollmeier A, Johne R, Praefcke GJK, Hildt E (2021): Identification of the interferon-inducible GTPase GBP1 as major restriction factor for the Hepatitis E virus.
J Virol 95: e01564-20.
Online-Abstract

Görgülü E, Gu W, Trebicka J, Mücke VT, Mücke MM, Friedrich-Rust M, Bojunga J, Zeuzem S, Finkelmeier F, Peiffer KH (2022): Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: another collateral damage of the COVID-19 pandemic?.
Gut 71: 1036-1038.
Text

Hastert FD, Hein S, von Rhein C, Benz NI, Husria Y, Oberle D, Maier TJ, Hildt E, Schnierle BS (2022): The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination.
Vaccines (Basel) 10: 794.
Text

Hastert FD, Henss L, von Rhein C, Gerbeth J, Wieters I, Borgans F, Khodamoradi Y, Zacharowski K, Rohde G, Vehreschild MJGT, Schnierle B (2022): Longitudinal Analysis of Coronavirus-Neutralizing Activity in COVID-19 Patients.
Viruses 14: 882.
Text

Hein S, Benz NI, Eisert J, Herrlein ML, Oberle D, Dreher M, Stingl JC, Hildt C, Hildt E (2021): Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes.
Vaccines (Basel) 9: 1419.
Online-Abstract

Hein S, Herrlein ML, Mhedhbi I, Bender D, Haberger V, Benz N, Eisert J, Stingl J, Dreher M, Oberle D, Schulze J, Mache C, Budt M, Hildt C, Wolff T, Hildt E (2022): Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera towards SARS-CoV-2 viruses.
Allergy 77: 2080–2089.
Online-Abstract

Hein S, Mhedhbi I, Zahn T, Sabino C, Benz NI, Husria Y, Renelt PM, Braun F, Oberle D, Maier TJ, Hildt C, Hildt E (2022): Quantitative and Qualitative Difference in Antibody Response against Omicron and Ancestral SARS‐CoV‐2 after Third and Fourth Vaccination.
Vaccines (Basel) 10: 796.
Text

Henss L, Auste A, Schürmann C, Schmidt C, von Rhein C, Mühlebach MD, Schnierle BS (2021): The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection.
J Gen Virol 102: 001574.
Text

Herrlein ML, Hein S, Zahn T, Mhedhbi I, Raupach J, Husria Y, Benz NI, Eisert J, Bender D, Haberger V, Hastert FD, Henss L, Schnierle BS, Stingl JC, Dreher M, Hildt E (2022): Comparative Investigation of Methods for Analysis of SARS-CoV-2-Spike-Specific Antisera.
Viruses 14: 410.
Text

Herrlein ML, Schmanke P, Elgner F, Sabino C, Akhras S, Bender D, Glitscher M, Tabari D, Scholl C, Stingl J, Hildt E (2022): Catch Me if You Can: the Crosstalk of Zika Virus and the Restriction Factor Tetherin.
J Virol 96: e0211721.
Online-Abstract

Hildt E (2022): Virale Hepatitis – ein versteckter Killer.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65: 137-138.
Text

Hildt E (2022): Übersicht über die in der EU zugelassenen COVID-19-Impfstoffe – von der Technologie über die klinische Prüfung zur Zulassung.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65: 1237–1243.
Text

Hildt E, Schaade L (2022): Impfungen als Instrument der Pandemiebewältigung.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65: 1235-1236.
Text

Huber S, Braun NJ, Schmacke LC, Quek JP, Murra R, Bender D, Hildt E, Luo D, Heine A, Steinmetzer T (2022): Structure-Based Optimization and Characterization of Macrocyclic Zika Virus NS2B-NS3 Protease Inhibitors.
J Med Chem 65: 6555-6572.
Online-Abstract

Kaiser LM, Harms M, Sauter D, Rawat VPS, Glitscher M, Hildt E, Tews D, Hunter Z, Münch J, Buske C (2021): Targeting of CXCR4 by the Naturally Occurring CXCR4 Antagonist EPI-X4 in Waldenström’s Macroglobulinemia.
Cancers (Basel) 13: 826.
Text

Mitterreiter J, Scheiblauer H, Fiedler S, Kreß J (2022): Sicherheit von Blut und Blutprodukten: Testmethoden zum Nachweis der Hepatitisviren B, C und E.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65: 209-219.
Text

Petry M, Palus M, Leitzen E, Mitterreiter JG, Huang B, Kröger A, Verjans GMGM, Baumgärtner W, Rimmelzwaan GF, Ruzek D, Osterhaus A, Prajeeth CK (2021): Immunity to TBEV Related Flaviviruses with Reduced Pathogenicity Protects Mice from Disease but Not from TBEV Entry into the CNS.
Vaccines (Basel) 9: 196.
Online-Abstract

Reitz S, Schwantes A (2022): Proceedings of 2019 Viral Clearance Symposium, Session 1: Viral Clearance Strategies and Case Studies.
PDA J Pharm Sci Technol 76: 297-305.
Online-Abstract

Roush D, Blümel J (2022): Proceedings of 2019 Viral Clearance Symposium, Session 4: Viral Clearance Strategy and Process Understanding.
PDA J Pharm Sci Technol 76: 323-338.
Online-Abstract

Sabino C, Bender D, Herrlein ML, Hildt E (2021): The epidermal growth factor receptor is a relevant host factor in the early stages of Zika virus life cycle in vitro.
J Virol 95: e0119521.
Online-Abstract

Schmidt C, Haefner E, Gerbeth J, Beissert T, Sahin U, Perkovic M, Schnierle BS (2022): A taRNA vaccine candidate induces a specific immune response that protects mice against Chikungunya virus infections.
Mol Ther Nucleic Acids 28: 743-754.
Text

Schmidt C, Hastert FD, Gerbeth J, Beissert T, Sahin U, Perkovic M, Schnierle BS (2022): A Bivalent Trans-Amplifying RNA Vaccine Candidate Induces Potent Chikungunya and Ross River Virus Specific Immune Responses.
Vaccines (Basel) 10: 1374.
Text

Schmidt C, Perkovic M, Schnierle BS (2021): Development of a Sensitive Detection Method for Alphaviruses and Its Use as a Virus Neutralization Assay.
Viruses 13: 1191.
Text

Schmidt C, Schnierle BS (2022): Chikungunya Vaccine Candidates: Current Landscape and Future Prospects.
Drug Des Devel Ther 16: 3663-3673.
Online-Abstract

Schnierle BS (2021): Reply to Ringlander et al..
J Infect Dis 223: 1833.

Schnierle BS (2022): Monkeypox Goes North: Ongoing Worldwide Monkeypox Infections in Humans.
Viruses 14: 1874.
Text

Sediri-Schön H, Lange J, Grabski E, Wagner R, Hildt E (2022): Chargenprüfung als wesentliche Säule der Versorgung mit sicheren und wirksamen Impfstoffen.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65: 1244-1250.
Text

Specht R, Schwantes A (2022): Proceedings of 2019 Viral Clearance Symposium, Session 2: New Modalities in Chromatography and Adsorptive Filters.
PDA J Pharm Sci Technol 76: 306-314.
Online-Abstract

Srivastav S, Dankov A, Adanalic M, Grzeschik R, Tran V, Pagel-Wieder S, Gessler F, Spreitzer I, Scholz T, Schnierle B, Anastasiou OE, Dittmer U, Schlücker S (2021): Rapid and Sensitive SERS-Based Lateral Flow Test for SARS-CoV2-Specific IgM/IgG Antibodies.
Anal Chem 93: 12391-12399.
Online-Abstract

Stelzl E, Ciesek S, Cornberg M, Maasoumy B, Heim A, Chudy M, Olivero A, Miklau FN, Nickel A, Reinhardt A, Dietzsch M, Kessler HH (2021): Reliable quantification of plasma HDV RNA is of paramount importance for treatment monitoring: A European multicenter study.
J Clin Virol 142: 104932.
Online-Abstract

Taconet L, Seifner A, Baylis SA, Chudy M, Kreß J, Mathys E, Wirz M, Buchheit KH, Behr-Gross ME (2021): Detection of hepatitis C virus and parvovirus B19 in human plasma pools by nucleic-acid amplification techniques - Trends in results of EDQM proficiency testing studies from 2004 to 2018.
Biologicals 71: 9-19.
Online-Abstract

Thibau A, Vaca DJ, Bagowski M, Hipp K, Bender D, Ballhorn W, Linke D, Kempf VAJ (2022): Adhesion of Bartonella henselae to Fibronectin Is Mediated via Repetitive Motifs Present in the Stalk of Bartonella Adhesin A.
Microbiol Spectr 10: e02117-22.
Text

Vandeputte J, Saville M, Cavaleri M, Friede M, Hacker A, Mueller SO, Rizzi R, Smith D, Thirstrup S, Wagner R, Baay M, Neels P (2021): IABS/CEPI platform technology webinar: Is it possible to reduce the vaccine development time?.
Biologicals 71: 55-60.
Text

von Rhein C, Scholz T, Henss L, Kronstein-Wiedemann R, Schwarz T, Rodionov RN, Corman VM, Tonn T, Schnierle BS (2021): Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma.
J Virol Methods 288: 114031.
Text

Wagner R, Hildt E, Grabski E, Sun Y, Meyer H, Lommel A, Keller-Stanislawski B, Müller-Berghaus J, Cichutek K (2021): Accelerated Development of COVID-19 Vaccines: Technology Platforms, Benefits, and Associated Risks.
Vaccines (Basel) 9: 747.
Text

Wagner R, Meißner J, Grabski E, Sun Y, Vieths S, Hildt E (2022): Regulatory concepts to guide and promote the accelerated but safe clinical development and licensure of COVID-19 vaccines in Europe.
Allergy 77: 72-82.
Online-Abstract

Zahn T, Mhedhbi I, Hein S, Raupach J, Miskey C, Husria Y, Bayanga K, Bartel D, Vieths S, Ivics Z, Oberle D, Keller-Stanislawski K, Herrlein ML, Maier TJ, Hildt E (2022): Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19.
Allergy 77: 2053-2066.
Online-Abstract

Anliker B, Childs L, Rau J, Renner M, Schüle S, Schuessler-Lenz M, Sebe A (2022): Regulatory Considerations for Clinical Trial Applications with CRISPR-Based Medicinal Products.
CRISPR J 5: 364-376.
Online-Abstract

Arroyo M, Hastert FD, Zhadan A, Schelter F, Zimbelmann S, Rausch C, Ludwig AK, Carell T, Cardoso MC (2022): Isoform-specific and ubiquitination dependent recruitment of Tet1 to replicating heterochromatin modulates methylcytosine oxidation.
Nat Commun 13: 5173.
Text

Baylis SA, Adlhoch C, Childs L, and the HEV Sequencing Study Group (2022): An Evaluation of Hepatitis E Virus Molecular Typing Methods.
Clin Chem 68: 181-191.
Text

Bitar L, Schumann U, König R, Zipp F, Schmidt MHH (2021): Targeting Immune Modulators in Glioma While Avoiding Autoimmune Conditions.
Cancers (Basel) 13: 3524.
Online-Abstract

Canet-Pons J, Sen NE, Arsovíc A, Almaguer-Mederos LE, Halbach MV, Key J, Döring C, Kerksiek A, Picchiarelli G, Cassel R, René F, Dieterlé S, Fuchs NV, König R, Dupuis L, Lütjohann D, Gispert S, Auburger G (2021): Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression.
Neurobiol Dis 152: 105289.
Text

König R, Münk C (2021): Special Issue: 'Innate Immune Sensing of Viruses and Viral Evasion'.
Viruses 13: 567.
Text

Reimann M, Schrezenmeier JF, Richter-Pechanska P, Dolnik A, Hick TP, Schleich K, Cai X, Fan DNY, Lohneis P, Masswig S, Denker S, Busse A, Knittel G, Flümann R, Childs D, Childs L, Gätjens-Sanchez AM, Bullinger L, Rosenwald A, Reinhardt HC, Schmitt CA (2021): Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas.
Blood 137: 2785-2799.
Online-Abstract

Schott K, Majer C, Bulashevska A, Childs L, Schmidt MHH, Rajalingam K, Munder M, König R (2022): SAMHD1 in cancer: curse or cure?.
J Mol Med (Berl) 100: 351-372.
Online-Abstract

Yoh SM, Mamede JI, Lau D, Ahn N, Sánchez-Aparicio MT, Temple J, Tuckwell A, Fuchs NV, Cianci GC, Riva L, Curry H, Yin X, Gambut S, Simons LM, Hultquist JF, König R, Xiong Y, García-Sastre A, Böcking T, Hope TJ, Chanda SK (2022): Recognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nascent HIV-1 DNA.
Mol Cell 82: 2871-2884.e6.
Online-Abstract

Krijnse Locker J (2022): Tips and tricks of viruses; unconventional egress.
Mol Microbiol 117: 1291-1292.
Text

Tonnemacher S, Folly-Klan M, Gazi AD, Schäfer S, Pénard E, Eberle R, Kunz R, Walther P, Krijnse Locker J (2022): Vaccinia virus H7-protein is required for the organization of the viral scaffold protein into hexamers.
Sci Rep 12: 13007.
Text

Lohse S, Sternjakob-Marthaler A, Lagemann P, Schöpe J, Rissland J, Seiwert N, Pfuhl T, Müllendorff A, Kiefer LS, Vogelgesang M, Vella L, Denk K, Vicari J, Zwick A, Lang I, Weber G, Geisel J, Rech J, Schnabel B, Hauptmann G, Holleczek B, Scheiblauer H, Wagenpfeil S, Smola S (2022): German federal-state-wide seroprevalence study of 1st SARS-CoV-2 pandemic wave shows importance of long-term antibody test performance.
Commun Med (Lond) 2: 52.
Text

Mitterreiter J, Scheiblauer H, Fiedler S, Kreß J (2022): Sicherheit von Blut und Blutprodukten: Testmethoden zum Nachweis der Hepatitisviren B, C und E.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65: 209-219.
Text

Scheiblauer H, Filomena A, Nitsche A, Puyskens A, Corman VM, Drosten C, Zwirglmaier K, Lange C, Emmerich P, Müller M, Knauer O, Nübling CM (2021): Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021.
Euro Surveill 26: 2100441.
Text

Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C (2022): Antibody response to SARS-CoV-2 for more than one year − kinetics and persistence of detection are predominantly determined by avidity progression and test design.
J Clin Virol 146: 105052.
Text